Consulting fees
Consulting Fees [Member]
Consulting Fees [Member]
ACTOS
Actos [Member]
Actos
Revision of Prior Period [Axis]
Revision of Prior Period [Axis]
Disclosure of contingent liabilities [line items]
Disclosure of contingent liabilities [line items]
Total interest expense
Interest expense
Disclosure of geographical areas [line items]
Disclosure of geographical areas [line items]
Unused tax credits
Unused tax credits for which no deferred tax asset recognised
Foreign currency exchange
Foreign Exchange Hedge [Member]
Foreign Exchange Hedge
Acquisition of property, plant and equipment
Purchase of property, plant and equipment, classified as investing activities
Entity listings, exchange [Axis]
Entity Listings, Exchange [Axis]
Changes in unrecognized deferred tax assets and deferred tax liabilities
Tax Effect Of Changes In Unrecognized Deferred Tax Assets And Liabilities In Determining Taxable Profit (Loss)
Tax Effect Of Changes In Unrecognized Deferred Tax Assets And Liabilities In Determining Taxable Profit (Tax Loss)
Dividends received
Dividends received, classified as investing activities
Salary
Wages and salaries
Entity file number
Entity File Number
Dividends
Dividends paid, ordinary shares
Impairment losses
Impairment losses
Impairment loss recognised in profit or loss, intangible assets other than goodwill
Phantom stock appreciation rights (PSARs)
Phantom Stock Appreciation Rights [Member]
Phantom Stock Appreciation Rights [Member]
Entity reorganizations/Divestments
Tax Effect Of Entity Reorganizations And Divestments In Determining Taxable Profit (Loss)
Tax Effect Of Entity Reorganizations And Divestments In Determining Taxable Profit (Loss)
Deferred tax benefit
Deferred tax expense (income)
Deferred tax expense (income)
Other
Other finance income
Schedule of Intangible Assets Associated with Products
Disclosure of detailed information about intangible assets [text block]
Increase (decrease) in provisions
Increase (decrease) in other provisions
Levels of fair value hierarchy
Levels of fair value hierarchy [domain]
Sales of pharmaceutical products
Pharmaceutical Products [Member]
Pharmaceutical Products [Member]
Net defined benefit liability (asset) [axis]
Net defined benefit liability (asset) [axis]
Before tax effects
Other Comprehensive Income, Before Tax, Hedging Cost
Other Comprehensive Income, Before Tax, Hedging Cost
3rd year
Between two and three years
Later than two years and not later than three years [member]
Cash and cash equivalents [abstract]
Cash and cash equivalents [abstract]
Schedule of Reconciliation of Liabilities Arising from Financing Activities
Disclosure of reconciliation of liabilities arising from financing activities [text block]
Equity-Settled LTIP
Equity Settled Long-Term Incentive Plan [Member]
Equity Settled Long-Term Incentive Plan
Machinery and vehicles
Machinery And Vehicles [Member]
Machinery And Vehicles [Member]
Cash generated from operations
Cash flows from (used in) operations
Other
Other tax effects for reconciliation between accounting profit and tax expense (income)
Changes in fair value of financial assets measured at fair value through other comprehensive income
Changes in fair value of financial assets measured at fair value through OCI
Other comprehensive income, net of tax, gains (losses) from investments in equity instruments
Sales
Sales, fair value measurement, assets
Issuance of shares
Stock Issued During Period, Shares
Stock Issued During Period, Shares
Schedule of Reconciliation of Changes in Right-of-use Assets
Disclosure of quantitative information about right-of-use assets [text block]
2018 EUR Unsecured Senior Notes – fixed rate
Senior Notes 2018 EUR Fixed Rate [Member]
Senior Notes 2018 EUR Fixed Rate [Member]
Disclosure of detailed information about borrowings [table]
Disclosure of detailed information about borrowings [table]
Vested (in shares)
Number of other equity instruments exercised or vested in share-based payment arrangement
Initial up-front payments, milestone payments, and other asset acquisitions
Payments For Collaboration And Licensing Arrangements
Payments For Collaboration And Licensing Arrangements
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Others
Other PDT [Member]
Other PDT Immunology [Member]
As of beginning of the year
As of end of the year
Intangible assets and goodwill
Derivative liabilities
Derivative Liabilities [Member]
Derivative Liabilities [Member]
LEUPLIN/ENANTONE
Leuplin/Enantone [Member]
Leuplin/Enantone
Statement of comprehensive income [abstract]
Statement of comprehensive income [abstract]
Proceeds from sales of shares in associates
Proceeds from sales of interests in associates
Statement of changes in equity [line items]
Statement of changes in equity [line items]
Attributable to:
Comprehensive income attributable to [abstract]
Hedging cost
Reserve Of Hedging Cost [Member]
Reserve Of Hedging Cost [Member]
Weighted average exercise price (JPY)
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Provisions for legal proceedings related to AMITIZA (Note 31)
Expenses Related To Provisions For Legal Proceedings
Expenses Related To Provisions For Legal Proceedings
Asia (excluding Japan & China)
Asia, Excluding Japan And China [Member]
Asia, Excluding Japan And China
Bonds
Bonds, Liabilities [Member]
Bonds [Member]
Disclosure of number and weighted average remaining contractual life of outstanding share options [table]
Disclosure of number and weighted average remaining contractual life of outstanding share options [table]
Disclosure of geographical areas [table]
Disclosure of geographical areas [table]
Proceeds from bonds
Proceeds from issue of bonds, notes and debentures
Dividends proposed or declared before financial statements authorised for issue but not recognised as distribution to owners
Dividends proposed or declared before financial statements authorised for issue but not recognised as distribution to owners
Measured at fair value through profit or loss
Financial assets at fair value through profit or loss, category [member]
Other operating expenses:
Other Operating Expenses [Abstract]
Other Operating Expenses [Abstract]
Performance stock units (PSUs)
Performance Share Units [Member]
Performance Share Units
Commitment Facilities
Commitment Facilities [Member]
Commitment Facilities
Current
Current [member]
Foreign currency translation differences and others
Increase (decrease) through net exchange differences, intangible assets and goodwill
Statement of financial position [abstract]
Statement of financial position [abstract]
Other operating expenses
Other operating income (expense)
Cover [Abstract]
Acquisition of treasury shares
Payments to acquire or redeem entity's shares
Maximum
Maximum [Member]
Changes in Presentation
Disclosure of reclassifications or changes in presentation [text block]
Dividend income
Dividend Income [Abstract]
Dividend Income [Abstract]
Decreases (reversed)
Unused provision reversed, other provisions
Impaired product-related intangible assets
Impaired Product-Related Intangible Assets [Member]
Impaired Product-Related Intangible Assets [Member]
Provisions
Description of accounting policy for provisions [text block]
Basis of Consolidation
Description of accounting policy for subsidiaries [text block]
Albumin
Albumin [Member]
Albumin [Member]
Classes of intangible assets other than goodwill [axis]
Classes of intangible assets other than goodwill [axis]
Trade receivables
Impairment loss allowance, trade receivables at the beginning of the period
Impairment loss allowance, trade receivables at the end of the period
Trade receivables
Amount reclassified to profit or loss
Amounts Recognized In Profit Or Loss [Abstract]
Amounts Recognized In Profit Or Loss
Disclosure of sensitivity analysis for actuarial assumptions [table]
Disclosure of sensitivity analysis for actuarial assumptions [table]
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. [Member]
Shire Human Genetic Therapies, Inc.
Entity shell company
Entity Shell Company
Share-based Payment Arrangement [Abstract]
Share-Based Payment Arrangement [Abstract]
Share-based Payment Arrangement [Abstract]
Share premium
Share premium
Temporary differences associated with investments in subsidiaries, branches and associates and interests in joint arrangements for which deferred tax liabilities have not been recognised
Temporary differences associated with investments in subsidiaries, branches and associates and interests in joint arrangements for which deferred tax liabilities have not been recognised
Cash flows from financing activities:
Cash flows from financing activities
Cash flows from (used in) financing activities [abstract]
Japan tax rate change
Japan Tax Rate Change [Member]
Japan Tax Rate Change
Contract liabilities
Contract liabilities [abstract]
Classes of liabilities [domain]
Classes of liabilities [domain]
Hyperinflation effect expense
Hyperinflation Effect Expense
Hyperinflation Effect Expense
Total comprehensive income (loss) for the year
Comprehensive income
Additional potential payment, pharmaceutical asset acquisition agreement
Additional Potential Payment, Pharmaceutical Asset Acquisition Agreement
Additional Potential Payment, Pharmaceutical Asset Acquisition Agreement
Investments in subsidiaries and associates
Investments In Affiliated Entity Related Temporary Differences [Member]
Investments In Affiliated Entity Related Temporary Differences [Member]
Severance
Severance [Member]
Employee Severance [Member]
Hedging cost:
Hedging Cost [Abstract]
Hedging Cost [Abstract]
Summary of Changes in Present Value of the Defined Benefit Obligations
Disclosure of net defined benefit liability (asset) [text block]
Work-in-process
Current work in progress
Basis of Preparation
Disclosure of basis of preparation of financial statements [text block]
Development funding agreement, receivable
Development Funding Agreement, Receivable
Development Funding Agreement, Receivable
2024 USD Unsecured Senior Notes – fixed rate
Senior Notes 2024 USD Unsecured Senior Notes Fixed Rate [Member]
Senior Notes 2024 USD Unsecured Senior Notes Fixed Rate
Document fiscal period focus
Document Fiscal Period Focus
Total assets
Assets
Assets
Other, net
Other inflows (outflows) of cash, classified as investing activities
Litigation Case [Domain]
Litigation Case [Domain]
Unbilled receivables
Contract assets
Total
Other financial liabilities
Amounts arising during the year
Gains (losses) on exchange differences on translation of foreign operations, before tax
Income Taxes
Description of accounting policy for income tax [text block]
Transfer from Equity-Settled ESOP (in shares)
Number Of Share Options Transferred To Liability Settled In Employee Stock Ownership Plan, Share-Based Payment Arrangement
Number Of Share Options Transferred To Liability Settled In Employee Stock Ownership Plan, Share-Based Payment Arrangement
As of beginning of the year (in shares)
As of end of the year (in shares)
Number of other equity instruments outstanding in share-based payment arrangement
Business Combinations
Description of accounting policy for business combinations [text block]
Goodwill
Description of accounting policy for goodwill [text block]
Investment, name [Domain]
Investment, Name [Domain]
Total Oncology
Oncology [Member]
Oncology [Member]
Trading symbol
Trading Symbol
Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]
Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]
[Line Items] for Disclosure of fair value measurement of assets and liabilities [Table]
Types of interest rates [axis]
Types of interest rates [axis]
Revenue
Revenue
Disclosure of detailed information about business combination [abstract]
Investments in financial assets at fair value through P&L
Financial assets at fair value through profit or loss
Entity address, city or town
Entity Address, City or Town
Forward interest rate contracts
Forward contract [member]
Bonds and Loans
Disclosure of borrowings [text block]
Phantom stock appreciation rights and restricted stock units
Phantom Stock Appreciation Rights And Restricted Stock Units [Member]
Phantom Stock Appreciation Rights And Restricted Stock Units [Member]
Share capital
Issued capital [member]
Other non-current liabilities
Non-current
Other non-current liabilities
Classes of other provisions [domain]
Classes of other provisions [domain]
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]
Fair Value, Asset And Liabilities Measured On Recurring Basis, Unobservable Input Reconciliation [Table]
Fair Value, Asset And Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]
Total other components of equity
Other reserves [member]
Losses on litigation settlements
Losses on litigation settlements
Indefinite
Indefinite Years [Member]
Indefinite Years [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities [line items]
Cash and cash equivalents
Cash And Cash Equivalents1 [Member]
Cash And Cash Equivalents [Member]
Loss on sales and disposal of property, plant and equipment
Gains (losses) on disposals of property, plant and equipment
Disclosure of quantitative information about right-of-use assets [table]
Disclosure of quantitative information about right-of-use assets [table]
Entity emerging growth company
Entity Emerging Growth Company
Changes in ownership
Increase (decrease) through change in equity of subsidiaries, equity
Number of lawsuits
Loss Contingency, Number Of Lawsuits
Loss Contingency, Number Of Lawsuits
Assets and Disposal Groups Held for Sale
Disclosure of non-current assets or disposal groups classified as held for sale [text block]
BioLife Plasma Services LP
BioLife Plasma Services LP [Member]
BioLife Plasma Services LP
Keros Therapeutic
Keros Therapeutic [Member]
Keros Therapeutic
Basis of Measurement
Explanation of measurement bases for financial instruments used in preparing financial statements [text block]
Reporting Entity
Disclosure of general information about financial statements [text block]
Assets held for sale
Current assets other than non-current assets or disposal groups classified as held for sale or as held for distribution to owners
Weighted-average share price for share options exercised (in JPY per share)
Weighted average share price for share options in share-based payment arrangement exercised during period at date of exercise
Transfers
Increase (decrease) through transfers, property, plant and equipment
Disposals and other decreases
Disposals, property, plant and equipment
Income tax expense (benefit) at Takeda’s domestic (Japanese) statutory tax rate of 30.6%
Tax expense (income) at applicable tax rate
Construction in progress
Construction in progress [member]
Over 90 days but within one year
Later than three months and not later than one year [member]
Assets
Assets [abstract]
Dyax Corp.
Dyax Corp. [Member]
Dyax Corp. [Member]
Department of Justice Civil Investigative Demands
Department of Justice Civil Investigative Demands [Member]
Department of Justice Civil Investigative Demands
Bad debt provision calculated by simplified approach
Bad Debt Provision Calculated By Simplified Approach [Member]
Bad Debt Provision Calculated By Simplified Approach [Member]
Takeda Farmaceutica Espana S.A.
Takeda Farmaceutica Espana S.A [Member]
Takeda Farmaceutica Espana S.A
Transfer to other comprehensive income associated with assets held for sale
Increase (Decrease) Through Transfer To Transfer To Other Comprehensive Income Associated With Assets Held For Sale, equity
Increase (Decrease) Through Transfer To Transfer To Other Comprehensive Income Associated With Assets Held For Sale, equity
2025 USD Unsecured Guaranteed Senior Notes – fixed rate
Unsecured US Dollar Denominated Senior Notes [Member]
Unsecured US Dollar Denominated Senior Notes
Types of antidilutive instruments [axis]
Types of antidilutive instruments [axis]
Disposal groups held for sale
Disposal groups classified as held for sale [member]
Current assets:
Current assets [abstract]
Gamma Delta T-Cell Therapy Platform And Associated Oncology Programs
Gamma Delta T-Cell Therapy Platform And Associated Oncology Programs [Member]
Gamma Delta T-Cell Therapy Platform And Associated Oncology Programs
Entity address, postal zip code
Entity Address, Postal Zip Code
Cash flow hedges:
Cash flow hedges [abstract]
Non-current assets:
Non-current assets [abstract]
Income Taxes
Disclosure of income tax [text block]
Document Information [Line Items]
Document Information [Line Items]
Defined benefit costs
Post-Employment Benefit Expense (Credit), Defined Benefit Plans
Post-Employment Benefit Expense (Credit), Defined Benefit Plans
Revenue
Description of accounting policy for recognition of revenue [text block]
Measurement input, EBITDA rate
Measurement Input, EBITDA Rate
Measurement Input, EBITDA Rate
Research and development expenses
Research And Development Related Temporary Differences [Member]
Research And Development Related Temporary Differences
Shire Acquisitions Investments Ireland Designated Activity Company
Shire Acquisitions Investments Ireland Designated Activity Company [Member]
Shire Acquisitions Investments Ireland Designated Activity Company [Member]
Interest paid
Interest paid, classified as financing activities
Baxalta Incorporated
Baxalta Incorporated [Member]
Baxalta Incorporated [Member]
Schedule of Stock Option Activities
Disclosure of number and weighted average exercise prices of share options [text block]
Software
Computer software [member]
Takeda (China) Holdings Co., Ltd.
Takeda (China) Holdings Co., Ltd. [Member]
Takeda (China) Holdings Co., Ltd. [Member]
Receivables from contracts with customers
Receivables from contracts with customers [abstract]
Extension of the carryforward period, Japanese earnings stripping rules
Extension Of The Carryforward Period, Japanese Earnings Stripping Rules [Member]
Extension Of The Carryforward Period, Japanese Earnings Stripping Rules
Share-Based Payment Arrangement, Grantee Status [Domain]
Share-Based Payment Arrangement, Grantee Status [Domain]
Share-Based Payment Arrangement, Grantee Status [Domain]
Cash and deposits
Cash
Depreciation and impairment
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss
Investments in equity instruments
Equity instruments
Equity investments [member]
Disclosure of analysis of other comprehensive income by item [line items]
Disclosure of analysis of other comprehensive income by item [line items]
Related party transactions [abstract]
Cash flows from investing activities:
Cash flows from (used in) investing activities [abstract]
Contractual commitments for acquisition of pharmaceutical assets, payment
Contractual Commitments For Acquisition Of Pharmaceutical Assets, Payment
Contractual Commitments For Acquisition Of Pharmaceutical Assets, Payment
Dividends proposed or declared before financial statements authorised for issue but not recognised as distribution to owners per share
Dividends proposed or declared before financial statements authorised for issue but not recognised as distribution to owners per share
Contributions by the employees
Contributions by the employees
Decrease (increase) in net defined benefit liability (asset) resulting from contributions to plan by plan participants
Inventory Disclosure [Abstract]
Inventories [Abstract]
Inventories
Equity interest type [Axis]
Equity Interest Type [Axis]
Equity Interest Type [Axis]
Cash and cash equivalents
Description of accounting policy for determining components of cash and cash equivalents [text block]
Number of options (shares)
Reconciliation of number of shares outstanding [abstract]
Share-based compensation
Increase (decrease) through share-based payment transactions, equity
AC Immune SA
AC Immune SA [Member]
AC Immune SA
ADS
ADS [Member]
ADS
Net investment hedges
Hedges of net investment in foreign operations [member]
Zasocitinib (TAK-279)
TAK-279 [Member]
TAK-279
Total non-current assets
Non-current assets
Exchange differences on translation of foreign operations
Exchange differences on translation of foreign operations
Other comprehensive income, net of tax, exchange differences on translation of foreign operations
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Reconciliation of changes in fair value measurement, liabilities [abstract]
Total Gastroenterology
Gastroenterology [Member]
Gastroenterology [Member]
Before tax effects
Other comprehensive income, before tax, cash flow hedges
Reconciliation of changes in other provisions [abstract]
Reconciliation of changes in other provisions [abstract]
Disclosure of defined benefit plans [table]
Disclosure of defined benefit plans [table]
Russia/CIS
Russian Federation And Commonwealth Of Independent States [Member]
Russian Federation And Commonwealth Of Independent States [Member]
Other Operating Income and Expenses
Disclosure of other operating income (expense) [text block]
Classes of property, plant and equipment [axis]
Classes of property, plant and equipment [axis]
Outside the U.S.
Outside Of The United States [Member]
Outside Of The United States [Member]
Schedule of Contract Balances
Disclosure Of Contract Assets And Contract Liabilities [Table Text Block]
Disclosure Of Contract Assets And Contract Liabilities [Table Text Block]
Classes of property, plant and equipment [domain]
Classes of property, plant and equipment [domain]
Within 30 days
Not later than one month [member]
Actuarial assumptions [domain]
Actuarial assumptions [domain]
Total assets
Disposal Group, Including Discontinued Operation, Assets
Disposal Group, Including Discontinued Operation, Assets
Entity address, country
Entity Address, Country
Changes in tax effects of undistributed profit of overseas subsidiaries
Tax Effect Of Changes In Undistributed Profits Of Foreign Subsidiaries In Determining Taxable Profit (Loss)
Tax Effect Of Changes In Undistributed Profits Of Foreign Subsidiaries In Determining Taxable Profit (Loss)
Deferred income (Note 23)
Contract Liabilities, Deferred Income
Contract Liabilities, Deferred Income
Euro
Euro Member Countries, Euro
ADZYNMA
Adzynma [Member]
Adzynma
Non-current assets or disposal groups classified as held for sale or as held for distribution to owners [abstract]
Post-tax
Goodwill, Post-Tax [Member]
Goodwill, Post-Tax [Member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Foreign currency translation differences
Right-Of-Use Assets, Increase (Decrease) Through Net Exchange Differences
Right-Of-Use Assets, Increase (Decrease) Through Net Exchange Differences
AZILVA
Azilva [Member]
Azilva
Effects of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents
Interest received
Interest received, classified as investing activities
Foreign Currency Translations
Description of accounting policy for foreign currency translation [text block]
Document annual report
Document Annual Report
Percentage of reasonably possible increase in actuarial assumption
Percentage of reasonably possible increase in actuarial assumption
Remeasurement of defined benefit plans Return on plan assets
Remeasurement Changes in effect of asset ceiling
Decrease (increase) in net defined benefit liability (asset) resulting from return on plan assets excluding interest income or expense
Disclosure of detailed information about financial instruments [table]
Disclosure of detailed information about financial instruments [table]
Disclosure of transaction price allocated to remaining performance obligations [line items]
Disclosure of transaction price allocated to remaining performance obligations [line items]
Geographical areas [domain]
Geographical areas [domain]
Ownership of Voting Rights (%)
Proportion of voting rights held by non-controlling interests
Goodwill
Disposal Group, Including Discontinued Operation, Goodwill
Disposal Group, Including Discontinued Operation, Goodwill
Concentrations of risk [domain]
Concentrations of risk [domain]
Trade and other receivables
Total
Trade and other current receivables
Before tax effects
Other comprehensive income, before tax, financial assets measured at fair value through other comprehensive income
Entity interactive data current
Entity Interactive Data Current
Takeda Manufacturing Austria AG
Takeda Manufacturing Austria AG [Member]
Takeda Manufacturing Austria AG
Gain on sales of property, plant and equipment and investment property
Gains (Losses) On Disposals Of Property, Plant And Equipment And Investment Property
Gains (Losses) On Disposals Of Property, Plant And Equipment And Investment Property
Other Liabilities
Disclosure of other liabilities [text block]
Income taxes paid
Income taxes paid, classified as operating activities
Commitments and Contingencies Disclosure [Abstract]
Commitments And Contingencies Liabilities [Abstract]
Commitments And Contingencies Liabilities [Abstract]
Levels of fair value hierarchy [axis]
Levels of fair value hierarchy [axis]
Total equity attributable to owners of the Company
Equity attributable to owners of parent [member]
Finance expenses
Total
Finance costs
Takeda Manufacturing Singapore Pte. Ltd.
Takeda Manufacturing Singapore [Member]
Takeda Manufacturing Singapore
Schedule of Financial Assets at Fair Value
Disclosure of financial assets [text block]
Individual assets or cash-generating units [domain]
Individual assets or cash-generating units [domain]
Income tax expenses (benefit)
Adjustments for income tax expense
Latin America
Latin America [Member]
2020 USD Unsecured Senior Notes – fixed rate
Senior Notes 2020 USD Unsecured Senior Notes Fixed Rate [Member]
Senior Notes 2020 USD Unsecured Senior Notes Fixed Rate
Material Accounting Policies
Disclosure of material accounting policy information [text block]
Total
Other liabilities
Increase (decrease) in defined benefit obligation due to increase in assumption
Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption
Inventory write-offs
Inventory write-down
Schedule Of Provisions
Schedule Of Provisions [Table Text Block]
Schedule Of Provisions
Currency and interest risk
Currency And Interest Rate Risk [Member]
Currency And Interest Rate Risk [Member]
Increase (decrease) in number of shares outstanding (in shares)
Increase (decrease) in number of shares outstanding
ACTOS Antitrust Litigation
Actos Antitrust Litigation [Member]
Actos Antitrust Litigation
Financial Liabilities
Description of accounting policy for financial liabilities [text block]
Gains (losses) on cash flow hedges
Gains (losses) on cash flow hedges, net of tax
Intangible assets
Disposal Group, Including Discontinued Operation, Intangible Assets1
Disposal Group, Including Discontinued Operation, Intangible Assets1
Amounts arising during the year
Other comprehensive income, before tax, gains (losses) on remeasurements of defined benefit plans
Acquisition of investments
Purchase Of Investments
Purchase Of Investments
Tax effects
Income tax relating to remeasurements of defined benefit plans included in other comprehensive income
Entity central index key
Entity Central Index Key
Others
Other Product, Other [Member]
Other Product, Other [Member]
Other comprehensive income that will be reclassified to profit or loss, net of tax
Other comprehensive income that will be reclassified to profit or loss, net of tax
Cash and Cash Equivalents
Disclosure of cash and cash equivalents [text block]
As of beginning of the year (in shares)
As of end of the year (in shares)
Number of share options outstanding in share-based payment arrangement
Dividend income from financial assets measured at fair value through OCI and held at end of the period
Dividends recognised for investments in equity instruments designated at fair value through other comprehensive income, held at end of reporting period
Reconciliation of changes in deferred tax liability (asset) [abstract]
Reconciliation of changes in deferred tax liability (asset) [abstract]
Schedule of Assets Held for Sale and Disposal Groups
Disposal Groups, Including Discontinued Operations [Table Text Block]
Disposal Groups, Including Discontinued Operations [Table Text Block]
Interest expense on financial debt
Interest expense on debt instruments issued
Interest income
Finance Income, Interest Income [Abstract]
Interest Income [Abstract]
Attributable to:
Profit (loss), attributable to [abstract]
Liabilities and Equity
Equity and liabilities [abstract]
Government grants received
Proceeds from government grants, classified as financing activities
Amounts arising during the year
Gains (losses) on cash flow hedges, before tax
Reconciliation of changes in property, plant and equipment [abstract]
Reconciliation of changes in property, plant and equipment [abstract]
Entity filer category
Entity Filer Category
Intangible assets
Intangible Asset Related Temporary Differences [Member]
Intangible Asset Related Temporary Differences [Member]
Changes in fair value of financial assets measured at fair value through OCI and exchange differences on translation of foreign operations
Gains (losses) recognised in other comprehensive income including exchange differences, fair value measurement, assets
Foreign currency denominated bonds
Foreign Currency Denominated Bonds [Member]
Foreign Currency Denominated Bonds [Member]
Average foreign exchange rate
Average foreign exchange rate
Board of Directors resolution
Board Of Directors Meeting Resolution [Member]
Board Of Directors Meeting Resolution
Interest cost
Interest income on plan assets
Interest income
Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)
Additions and other increases
Additions other than through business combinations, property, plant and equipment
FRUZAQLA
Fruzaqla [Member]
Fruzaqla
Restructuring Type [Axis]
Restructuring Type [Axis]
Restructuring Type [Axis]
Classes of ordinary shares [domain]
Classes of ordinary shares [domain]
Operating profit
Profit (loss) from operating activities
Other receivables
Other current receivables
Schedule of Discounted Cash Flows Model
Schedule Of Discounted Cash Flow Model For Impairment Tests [Table Text Block]
Schedule Of Discounted Cash Flow Model For Impairment Tests
Reclassification adjustments to profit or (loss)
Share Of Other Comprehensive Income Of Associates And Joint Ventures Accounted For Using Equity Method, Reclassification Adjustments, Before Tax
Share Of Other Comprehensive Income Of Associates And Joint Ventures Accounted For Using Equity Method, Reclassification Adjustments, Before Tax
Major R&D Related Agreements
Major R&D Related Agreements [Member]
Major R&D Related Agreements
Takeda Italia S.p.A.
Takeda Italia S.p.A. [Member]
Takeda Italia S.p.A. [Member]
Entity address, address line one
Entity Address, Address Line One
Entity address, address line two
Entity Address, Address Line Two
Finance Expenses:
Finance Costs [Abstract]
Finance Costs [Abstract]
Weighted average remaining contractual life
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Share of other comprehensive loss of investments accounted for using the equity method
Share of other comprehensive income of associates and joint ventures accounted for using equity method, net of tax
Discontinued operations [member]
Discontinued operations [member]
Contractual commitments for acquisition of property, plant and equipment
Contractual commitments for acquisition of property, plant and equipment
Total Neuroscience
Neuroscience [Member]
Neuroscience [Member]
Other comprehensive income related to assets held for sale
Amount recognised in other comprehensive income and accumulated in equity relating to non-current assets or disposal groups held for sale [member]
Out-licensing and service income
Royalty And Services [Member]
Royalty And Services [Member]
Estimate of contributions expected to be paid to plan for next annual reporting period
Estimate of contributions expected to be paid to plan for next annual reporting period
2021 JPY Unsecured Senior Bonds – fixed rate
Senior Bonds 2021 JPY Unsecured Senior Bonds Fixed Rate [Member]
Senior Bonds 2021 JPY Unsecured Senior Bonds Fixed Rate
Provisions
Disclosure of provisions [text block]
Statement of cash flows [abstract]
Statement of cash flows [abstract]
Disclosure of financial assets [table]
Disclosure of financial assets [table]
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. [Member]
Takeda Pharmaceuticals U.S.A., Inc. [Member]
Other, net
Other inflows (outflows) of cash, classified as operating activities
Adjustments for current tax of prior periods
Adjustments for current tax of prior periods
Interest income on sublease
Interest Income On Sublease
Interest Income On Sublease
Interest income from financial assets measured at amortized cost
Interest revenue for financial assets measured at amortised cost
Counterparty Name [Domain]
Counterparty Name [Domain]
Long-term loans
Long-Term Loans
Long-Term Loans
Number of treasury shares sold (in shares)
Sale Of Treasury Shares, Shares
Sale Of Treasury Shares, Shares
Repayments of bonds
Repayments of bonds, notes and debentures
Differences in applicable tax rates of overseas subsidiaries
Tax effect of foreign tax rates
Hedged items [axis]
Hedged items [axis]
American depositary shares
American Depositary Shares [Member]
American Depositary Shares [Member]
Other
Other employee expense
Disclosure of products and services [line items]
Disclosure of products and services [line items]
Proportion of cost split in joint operation
Proportion Of Cost Split In Joint Operation
Proportion Of Cost Split In Joint Operation
Current liabilities:
Current liabilities [abstract]
Tax credits
Tax Effect Of Tax Credits In Determining Taxable Profit (Tax Loss)
Tax Effect Of Tax Credits In Determining Taxable Profit (Tax Loss)
Investments accounted for using the equity method
Investments accounted for using equity method
Takeda Argentina S.A.
Takeda Argentina S.A. [Member]
Takeda Argentina S.A.
Other financial liabilities
Current
Other current financial liabilities
JPY Syndicated Loans
JPY Syndicated Loans [Member]
JPY Syndicated Loans
Other comprehensive income (loss)
Other comprehensive income [abstract]
1.000% Senior Notes due 2029
1.000% Senior Notes Due 2029 [Member]
1.000% Senior Notes Due 2029
Contractual commitments for acquisition of intangible assets
Contractual commitments for acquisition of intangible assets
Disclosure of detailed information about hedging instruments [line items]
Disclosure of detailed information about hedging instruments [line items]
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Tax effects
Income tax relating to cash flow hedges included in other comprehensive income
Auditor Information [Abstract]
Auditor Information
Proportion of ownership interest in joint operation
Proportion of ownership interest in joint operation
Switzerland
SWITZERLAND
Classes of share capital [domain]
Classes of share capital [domain]
Takeda Pharma AG
Takeda Pharma AG [Member]
Takeda Pharma AG
Financial liabilities measured at fair value
Financial liabilities at fair value, class [member]
Reclassification to assets held for sale (Note 18)
Decrease through classified as held for sale, intangible assets and goodwill
Percentage of reasonably possible decrease in actuarial assumption
Percentage of reasonably possible decrease in actuarial assumption
Future salary increases
Actuarial assumption of expected rates of salary increases
China
CHINA
Contact personnel email address
Contact Personnel Email Address
Effect of asset ceiling
Effect of asset ceiling [member]
Exercise of stock options
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period
Reclassification adjustments to profit or (loss)
Reclassification adjustments on financial assets measured at fair value through other comprehensive income, before tax
Finance income
Total
Finance income
Classes of financial liabilities [axis]
Classes of financial liabilities [axis]
Takeda Pharmaceuticals America, Inc.
Takeda Pharmaceuticals America, Inc. [Member]
Takeda Pharmaceuticals America, Inc.
Classes of financial liabilities
Classes of financial liabilities [domain]
USD 500 million, short term loan
USD 500 Million, Short Term Loan [Member]
USD 500 Million, Short Term Loan
Document shell company report
Document Shell Company Report
Spread on variable interest rate
Borrowings, adjustment to interest rate basis
Tax effects
Income tax relating to investments in equity instruments included in other comprehensive income
Disclosure of other provisions [line items]
Disclosure of other provisions [line items]
Additions and other increases
Additions to right-of-use assets
Contributions by the employer
Decrease (increase) in net defined benefit liability (asset) resulting from resulting from contributions to plan by employer
Number of plans
Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans
Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans
Takeda Canada Inc.
Takeda Canada Inc. [Member]
Takeda Canada Inc.
Other Comprehensive Income (Loss)
Disclosure of analysis of other comprehensive income by item [text block]
Innovent Biologics, Inc.
Innovent Biologics, Inc. [Member]
Innovent Biologics, Inc.
Derivatives
Description of accounting policy for derivative financial instruments and hedging [text block]
Plan assets
Plan assets [member]
Gain on divestment of business and subsidiaries
Gain on divestment of business to Teva Takeda Yakuhin
Gains (Losses) On Disposal Of Business
Gains (Losses) On Disposal Of Business
Reserve of cash flow hedges, continuing hedges
Reserve of cash flow hedges, continuing hedges
Lease liabilities (Note 26)
Lease liabilities
Transaction costs of financial liabilities
Description of accounting policy for finance costs [text block]
Shire Ireland Finance Trading Limited
Shire Ireland Finance Trading Limited [Member]
Shire Ireland Finance Trading Limited [Member]
Others
Increase (decrease) through other changes, liabilities arising from financing activities
Provisions
Non-current
Non-current provisions
Takeda Austria GmbH
Takeda Austria GmbH [Member]
Takeda Austria GmbH [Member]
Discount rate
Actuarial assumption of discount rates
Number of CGU used in impairment testing
Number Of Cash Generating Unit Used In Impairment Testing
Number Of Cash Generating Unit Used In Impairment Testing
Minimum
Minimum [Member]
Liabilities arising from financing activities [domain]
Liabilities arising from financing activities [domain]
Schedule of Award Activity related to Other Awards
Disclosure of number and weighted average exercise prices of other equity instruments [text block]
Purchases
Purchases, fair value measurement, assets
Schedule of Other Financial Liabilities
Schedule Of Other Financial Liabilities [Table Text Block]
Schedule Of Other Financial Liabilities [Table Text Block]
Net profit (loss) used for calculation of earnings per share JPY (millions)
Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating diluted earnings per share
Summary of Amounts Related to Defined Benefit Pension Plans Recognized in Consolidated Statements of Income
Disclosure Of Defined Benefit Plan Expense Recognized In Profit Or Loss Explanatory [Table Text Block]
Disclosure Of Defined Benefit Plan Expense Recognized In Profit Or Loss Explanatory [Table Text Block]
Share capital
Issued capital
Financial liabilities associated with contingent consideration arrangements
Financial liabilities associated with contingent consideration arrangements
Contingent Consideration Liability [Member]
Contingent Consideration Liability [Member]
Personnel costs
Personnel Costs [Member]
Personnel Costs [Member]
Disclosure of reconciliation of liabilities arising from financing activities [line items]
Disclosure of reconciliation of liabilities arising from financing activities [line items]
Unused tax losses
Unused tax losses for which no deferred tax asset recognised
Other
Other intangible assets [member]
Tax effects
Income tax relating to exchange differences on translation of foreign operations included in other comprehensive income
Categories of financial assets [axis]
Categories of financial assets [axis]
Other
Increase (decrease) through net exchange differences, deferred tax liability (asset)
Non-current assets held for sale
Non-current assets held for sale [member]
Future cash outflow for leases not yet commenced
Future Cash Outflow For Leases Not Yet Commenced
Future Cash Outflow For Leases Not Yet Commenced
At the beginning of the year
As of the end of the year
Number of shares outstanding (in shares)
Number of shares outstanding
Products and services [axis]
Products and services [axis]
Financial liabilities
Carrying amount
Carrying amount
Financial liabilities
Other
Other temporary differences [member]
Immunoglobulin
Immunoglobulins
Immunoglobulin [Member]
Immunoglobulin [Member]
Inventories
Inventory Related Temporary Differences [Member]
Inventory Related Temporary Differences [Member]
Income tax (expenses) benefit
Total
Tax expense (income)
Subsequent Events
Disclosure of events after reporting period [text block]
Takeda U.S. Financing, Inc.
Takeda U.S. Financing, Inc. [Member]
Takeda U.S. Financing, Inc.
Document transition report
Document Transition Report
2024 Syndicated Hybrid Loans (Subordinated Loans)
2024 Syndicated Hybrid Loans, Subordinated Loans [Member]
2024 Syndicated Hybrid Loans, Subordinated Loans
TRINTELLIX
Trintellix [Member]
Trintellix [Member]
Cash flows from operating activities:
Cash flows from (used in) operating activities [abstract]
Commitments and Contingent Liabilities
Disclosure of other provisions, contingent liabilities and contingent assets [text block]
Share of profit (loss) of investments accounted for using the equity method
Share of profit (loss) of associates and joint ventures accounted for using equity method
Financial liabilities associated with contingent consideration arrangements (Note 26)
Contingent liabilities recognised in business combination at beginning of period
Contingent liabilities recognised in business combination at end of period
Contingent liabilities recognised in business combination
BIP, ESOP and Equity-Settled LTIP
Board Incentive Plan, Employee Stock Ownership Plan And Equity Settled Long-Term Incentive Plan [Member]
Board Incentive Plan, Employee Stock Ownership Plan And Equity Settled Long-Term Incentive Plan
Consolidated statements of financial position
Net Defined Benefit Liability (Asset) [Abstract]
Net Defined Benefit Liability (Asset) [Abstract]
Unsecured Senior Notes Assumed in Shire Acquisition
Unsecured Senior Notes Due June 2025 To June 2045 [Member]
Unsecured Senior Notes Due June 2020 To June 2045 [Member]
Disclosure of defined benefit plans [line items]
Disclosure of defined benefit plans [line items]
Selling, general and administrative expenses
Selling, general and administrative expense
Document period end date
Document Period End Date
Other operating income:
Other Operating Income [Abstract]
Other Operating Income [Abstract]
Selling, general and administrative expenses
Administrative expenses
Non-adjusting events after reporting period [domain]
Non-adjusting events after reporting period [domain]
ALOFISEL
Alofisel [Member]
Alofisel [Member]
Goodwill
Disclosure of goodwill [text block]
Maturity [axis]
Maturity [axis]
Cardinal Health Group
Cardinal Health Group [Member]
Cardinal Health Group
Other, net
Other inflows (outflows) of cash, classified as financing activities
Classes of financial instruments [axis]
Classes of financial instruments [axis]
Goodwill
Goodwill
Decreases (reversed)
Reversal of impairment loss recognised in profit or loss
Hedging cost
Hedging cost
Other Comprehensive Income, Net Of Tax, Hedging Cost
Other Comprehensive Income, Net Of Tax, Hedging Cost
Current and deferred tax relating to items credited (charged) directly to equity
Current and deferred tax relating to items credited (charged) directly to equity
Document type
Document Type
Classes of financial assets [axis]
Classes of financial assets [axis]
Changes in fair value of financial assets measured at fair value through other comprehensive income
Reserve of gains and losses on financial assets measured at fair value through other comprehensive income [member]
Treasury shares acquired (in shares)
Purchase Of Treasury Shares, Shares
Purchase Of Treasury Shares, Shares
Tax refunds and interest on tax refunds received
Income taxes refund, classified as operating activities
Total Rare Diseases
Rare Diseases [Member]
Rare Diseases [Member]
Foreign currency translation differences
Increase (decrease) through net exchange differences, intangible assets other than goodwill
Profit or loss [abstract]
Reclassification adjustments on cash flow hedges
Reclassification adjustments on cash flow hedges, net of tax
Statistical Measurement [Axis]
Statistical Measurement [Axis]
Land
Land [member]
Earnings per share [table]
Earnings per share [table]
Disclosure of analysis of single amount of discontinued operations [table]
Disclosure of analysis of single amount of discontinued operations [table]
Number of shares
Changes in number of shares outstanding [abstract]
Schedule of Age of Trade Receivables that are Past Due but not Impaired and Analysis of Impairment Analysis
Analysis Of Carrying Amount And Impairment Loss Allowance Of Trade Receivables By Due Date [Table Text Block]
Analysis Of Carrying Amount And Impairment Loss Allowance Of Trade Receivables By Due Date [Table Text Block]
Disclosure of financial liabilities [abstract]
Accrued labor cost
Employee-Related Liabilities
Employee-Related Liabilities
Reclassification to assets held for sale (Note 18)
Reclassifications To Assets Held For Sale, Intangible Assets Other Than Goodwill
Reclassifications To Assets Held For Sale, Intangible Assets Other Than Goodwill
Classes of assets [axis]
Classes of assets [axis]
Trade payables
Trade payables
Provisions
Current
Current provisions
Derivative assets
Derivative assets used for hedge of debts
Derivative Assets [Member]
Derivative Assets [Member]
5th year
Between four and five years
Later than four years and not later than five years [member]
Total Other
Other Product [Member]
Other Product [Member]
Types of share-based payment arrangements [domain]
Types of share-based payment arrangements [domain]
Tax effects
Income tax relating to financial assets measured at fair value through other comprehensive income included in other comprehensive income
Equity attributable to owners of the Company
Equity attributable to owners of parent
Earnings per share (JPY)
Earnings per share [abstract]
Range [axis]
Range [axis]
Number of individual retail pharmacies
Number Of Individual Retail Pharmacies
Number Of Individual Retail Pharmacies
Components of equity [axis]
Components of equity [axis]
Schedule of Financial Liabilities at Fair Value
Disclosure of financial liabilities [text block]
Profit (loss) before tax
Profit (loss) before tax
Proceeds from sales of business, net of cash and cash equivalents divested
Cash flows from losing control of subsidiaries or other businesses, classified as investing activities
Bonds and loans
Bonds And Loans [Member]
Bonds And Loans [Member]
Takeda Pharma AB
Takeda Pharma AB [Member]
Takeda Pharma AB
Disclosure Of Fair Value Measurement Of Assets And Liabilities [Table]
Disclosure Of Fair Value Measurement Of Assets And Liabilities [Table]
Disclosure of fair value measurement of assets and liabilities [Table]
Disclosure of maturity analysis for financial liabilities [Line Items]
Disclosure Of Maturity Analysis For Financial Liabilities [Line Items]
[Line Items] for Disclosure of maturity analysis for financial liabilities [Table]
2019 Hybrid Subordinated Bonds
2019 Hybrid Subordinated Bonds [Member]
Hybrid Subordinated Bonds [Member]
Equity and Other Equity Items
Disclosure of share capital, reserves and other equity interest [text block]
Tax effect of tax contingencies in determining taxable profit (loss)
Tax contingencies
Tax Effect Of Tax Contingencies In Determining Taxable Profit (Loss)
Tax Effect Of Tax Contingencies In Determining Taxable Profit (Loss)
Experience adjustments
Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from experience adjustments
Other current assets
Other current assets
TAK-079
TAK-079 [Member]
TAK-079
Disclosure of other provisions [table]
Disclosure of other provisions [table]
Donations and contributions
Donations and subsidies expense
Forward exchange contracts, buying
Forward Exchange Contract, Buying [Member]
Forward Exchange Contract, Buying [Member]
Schedule of Trade and Other Payables
Schedule Of Trade And Other Payables [Table Text Block]
Schedule Of Trade And Other Payables [Table Text Block]
Classes of financial instruments [domain]
Classes of financial instruments [domain]
Baxalta US Inc.
Baxalta US Inc. [Member]
Baxalta US Inc.
As of beginning of the year (in JPY per share)
As of end of the year (in JPY per share)
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement
Other
Other Liabilities, Miscellaneous
Other Liabilities, Miscellaneous
Dividend income from financial assets measured at fair value through OCI and disposed of during the period
Dividends recognised for investments in equity instruments designated at fair value through other comprehensive income, derecognised during period
Auditor Location
Auditor Location
2024 Hybrid bonds (subordinated bonds)
2024 Hybrid Subordinated Bonds [Member]
2024 Hybrid Subordinated Bonds
2025 USD Bilateral Loan
2025 USD Bilateral Loans [Member]
2025 USD Bilateral Loans
ADVATE & ADYNOVATE/ADYNOVI
Advate And Adynovate/Adynovi [Member]
Advate And Adynovate/Adynovi
Other Financial Assets
Disclosure Of Other Financial Assets [Text Block]
Disclosure Of Other Financial Assets [Text Block]
RESOLOR/MOTEGRITY
Resolor/Motegrity [Member]
Resolor/Motegrity
Loss on foreign currency exchange, net
Net foreign exchange loss
Products and services [domain]
Products and services [domain]
Operating Segment and Revenue Information
Disclosure of operating segments [text block]
Decrease in number of consolidated entities due to mergers and liquidations
Decrease In Consolidated Entities Due To Mergers And Liquidations
Decrease In Consolidated Entities Due To Mergers And Liquidations
Weighted-average number of ordinary shares outstanding during the year (basic) (in shares)
Weighted average number of ordinary shares used in calculating basic earnings per share
Interest paid
Interest Paid Classified As Financing Activities, Excluding Interest On Bonds And Loans
Interest Paid Classified As Financing Activities, Excluding Interest On Bonds And Loans
Remaining amortization period
Remaining amortisation period of intangible assets material to entity
Borrowing costs [abstract]
Borrowing costs [abstract]
Schedule of Deferred Taxes
Disclosure of temporary difference, unused tax losses and unused tax credits [text block]
Schedule Of Share-Based Compensation Arrangements By Share-Based Payment Award [Line Items]
Schedule Of Share-Based Compensation Arrangements By Share-Based Payment Award [Line Items]
[Line Items] for Schedule Of Share-Based Compensation Arrangements By Share-Based Payment Award [Table]
Weighted average exercise price (JPY)
Disclosure of range of exercise prices of outstanding share options [abstract]
Disclosure of detailed information about intangible assets [table]
Disclosure of detailed information about intangible assets [table]
Share-based compensation (expensed amount)
Key management personnel compensation, share-based payment
Changes recognized as finance income (expenses)
Gains (losses) on financial assets at fair value through profit or loss
Total
Borrowings
Entity well-known seasoned issuer
Entity Well-known Seasoned Issuer
Short-term investments
Short-term investments, classified as cash equivalents
Total
Other financial assets
Japan
Country of domicile [member]
Collaborations, Licensing Arrangements, Other Asset Acquisitions, and Others
Disclosure Of Collaborations And Licensing Arrangements, And Other Asset Acquisitions [Text Block]
Disclosure Of Collaborations And Licensing Arrangements [Text Block]
Schedule Of Share-Based Compensation Arrangements By Share-Based Payment Award [Table]
Schedule Of Share-Based Compensation Arrangements By Share-Based Payment Award1 [Table]
Schedule Of Share-Based Compensation Arrangements By Share-Based Payment Award [Table]
Impairment losses
Total
Impairment loss recognised in profit or loss, property, plant and equipment
Major customers [domain]
Major customers [domain]
Past service cost
Increase (decrease) in net defined benefit liability (asset) resulting from past service cost
Ratio of award or share per common stock
Number Of Instruments Or Interests Issued Or Issuable, Ratio Of Equity Interests Issued
Number Of Instruments Or Interests Issued Or Issuable, Ratio Of Equity Interests Issued
Short-term loans
Short-term borrowings [member]
Net cash used in financing activities
Cash flows from (used in) financing activities
Commencement of major litigation
Commencement of major litigation [member]
Gains (losses) on net investment hedges
Gains (losses) on hedges of net investments in foreign operations, net of tax
Counterparties [axis]
Counterparties [axis]
Earnings per Share
Description of accounting policy for earnings per share [text block]
Advance payments
Contract Liabilities, Advance Payments
Contract Liabilities, Advance Payments
Rebates payable
Provisions, Rebates Payable
Provisions, Rebates Payable
Others
Other Rare Diseases [Member]
Other Rare Diseases
Accumulated depreciation and accumulated impairment losses
Accumulated depreciation and accumulated impairment losses of ROU Assets
Accumulated depreciation, amortisation and impairment [member]
Financial Assets
Description of accounting policy for financial assets [text block]
Entity current reporting status
Entity Current Reporting Status
Fair value of plan assets
Total plan assets
Plan assets, at fair value
Between one and three years
Later than one year and not later than three years [member]
Treasury shares
Treasury shares
2025 JPY Unsecured-Senior Bonds – fixed rate
Unsecured JPY Denominated Senior Bonds [Member]
Unsecured JPY Denominated Senior Bonds
Foreign currency denominated loans
Foreign Currency Denominated Loans [Member]
Foreign Currency Denominated Loans [Member]
Statement of changes in equity [table]
Statement of changes in equity [table]
Actuarial assumptions [axis]
Actuarial assumptions [axis]
Summary of Finance Income and Expenses
Disclosure Of Finance Income (Costs) Explanatory [Table Text Block]
Disclosure Of Finance Income (Costs) Explanatory [Table Text Block]
Japan
JAPAN
Schedule of Disaggregation of Revenue Information
Disclosure of products and services [text block]
Settlement of forward exchange contracts designated as net investment hedges, net
Cash payments for futures contracts, forward contracts, option contracts and swap contracts, classified as investing activities
Bonds and loans
Current
Current borrowings and current portion of non-current borrowings
Cost of sales
Cost of sales
Non-cash items
Supplemental Disclosure Of Non-Cash Investing And Financing Information [Abstract]
Supplemental Disclosure Of Non-Cash Investing And Financing Information [Abstract]
Classes of assets
Classes of assets [domain]
Current fiscal year end date
Current Fiscal Year End Date
Proceeds from sales of property, plant and equipment
Proceeds from sales of property, plant and equipment, classified as investing activities
Trade and other receivables
Trade And Other Receivables [Member]
Trade And Other Receivables [Member]
Ireland
IRELAND
Types of hedges
Types of hedges [domain]
Dividends (in JPY per share)
Dividends paid, ordinary shares per share
Expense relating to leases of low-value assets that are not short-term leases expenses
Expense relating to leases of low-value assets for which recognition exemption has been used
Bottom of range
Bottom of range [member]
Disclosure of major customers [table]
Disclosure of major customers [table]
Impairment of Non-Financial Assets
Description of accounting policy for impairment of non-financial assets [text block]
Disclosure of detailed information about borrowings [line items]
Disclosure of detailed information about borrowings [line items]
Accrued expenses and provisions
Accrued Expenses And Provisions Related Temporary Differences [Member]
Accrued Expenses And Provisions Related Temporary Differences [Member]
Other Financial Liabilities
Disclosure Of Other Financial Liabilities [Text Block]
Disclosure Of Other Financial Liabilities [Table Text Block]
Other
Other Financial Liabilities [Member]
Other Financial Liabilities [Member]
Net profit (loss) for the year
Net profit (loss) for the year
Profit (loss)
Cash flow hedges
Cash flow hedges
Other comprehensive income, net of tax, cash flow hedges
Fair value of equity investments on dates of disposal
Fair value of investments in equity instruments designated at fair value through other comprehensive income at date of derecognition
Other financial assets
Other Financial Assets [Member]
Other Financial Assets [Member]
Impairment loss allowance
Financial assets
As of the beginning of the year
As of the end of the year
Financial assets
Total non-current liabilities
Non-current liabilities
Other
Other assets, amount contributed to fair value of plan assets
Changes in fair value of financial assets measured at fair value through OCI:
Financial assets measured at fair value through other comprehensive income [abstract]
Stock incentive plans
Stock Incentive Plans [Member]
Stock Incentive Plans
BIP
Board Incentive Plan [Member]
Board Incentive Plan [Member]
Average rate of hedging instrument
Average rate of hedging instrument
Changes in fair value of financial assets associated with contingent consideration due to other elements than time value
Gains (Losses) In Contingent Consideration, Fair Value Measurement, Assets
Gains (Losses) In Contingent Consideration, Fair Value Measurement, Assets
Amounts arising during the year
Share Of Other Comprehensive Income Of Associates And Joint Ventures Accounted For Using Equity Method, Gains (Losses), Before Tax
Share Of Other Comprehensive Income Of Associates And Joint Ventures Accounted For Using Equity Method, Gains (Losses), Before Tax
Document registration statement
Document Registration Statement
Property
Real estate, amount contributed to fair value of plan assets
Depreciation expenses
Depreciation, right-of-use assets
Marketed Products
Marketed Products [Member]
Marketed Products [Member]
Temporary difference, unused tax losses and unused tax credits [domain]
Temporary difference, unused tax losses and unused tax credits [domain]
Convertible notes
Investments in convertible notes
Convertible Notes [Member]
Convertible Notes [Member]
Retained earnings
Retained earnings [member]
Development funding agreement, increase (decrease) in receivable
Development Funding Agreement, Increase (Decrease) In Receivable
Development Funding Agreement, Increase (Decrease) In Receivable
Borrowings [abstract]
Finance Income and Expenses
Disclosure of finance income (cost) [text block]
Schedule of Inventories
Schedule Of Inventory [Table Text Block]
Schedule of Inventory, Current [Table Text Block]
2nd year
Between one and two years
Later than one year and not later than two years [member]
Disclosure of contingent liabilities [table]
Disclosure of contingent liabilities [table]
ESOP
Employee Stock Ownership Plan [Member]
Employee Stock Ownership Plan [Member]
Present value of defined benefit obligation
Present value of defined benefit obligation [member]
Leases
Description of accounting policy for leases [text block]
Forward exchange contracts
Forward Exchange Contracts [Member]
Forward Exchange Contracts
Assets and liabilities not classified as held for sale
Assets and liabilities not classified as held for sale [member]
Takeda Manufacturing U.S.A., Inc.
Takeda Manufacturing U.S.A., Inc. [Member]
Takeda Manufacturing U.S.A., Inc.
Analysis of income and expense [abstract]
Analysis of income and expense [abstract]
Deductible temporary differences
Deductible temporary differences for which no deferred tax asset is recognised
Schedule of Sensitivity Analysis for Actuarial Assumptions
Disclosure of sensitivity analysis for actuarial assumptions [text block]
Forfeited before vesting (in shares)
Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Forfeited Before Vesting
Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Forfeited Before Vesting
Depreciation and amortization
Depreciation and amortisation expense
Business contact
Business Contact [Member]
Discount rate used in current estimate of value in use
Discount rate used in current estimate of value in use
Liabilities:
Liabilities [abstract]
Bonds
Bonds issued
Tokyo Interbank Offered Rate (TIBOR)
Tokyo Interbank Offered Rate (TIBOR) [Member]
Tokyo Interbank Offered Rate (TIBOR)
Total Vaccines
Vaccines [Member]
Vaccines
Teva Takeda Pharma Ltd.
Teva Takeda Pharma Ltd. [Member]
Teva Takeda Pharma Ltd. [Member]
Financial assets measured at fair value
Financial assets at fair value, class [member]
Interest income from financial assets measured at fair value through OCI
Interest revenue for financial assets measured at fair value through other comprehensive income
Reclassification to assets held for sale (Note 18)
Decrease through classified as held for sale, property, plant and equipment
Revenue from performance obligations satisfied or partially satisfied in previous periods
Revenue from performance obligations satisfied or partially satisfied in previous periods
Others
Other Gastroenterology [Member]
Other Gastroenterology [Member]
Categories of financial assets
Categories of financial assets [domain]
Provisions [abstract]
Provisions [abstract]
Carrying amount
Carrying amount [member]
Schedule of Dividends Declared and Paid
Disclosure of dividends [text block]
Takeda Pharmaceuticals Limited Liability Company
Takeda Pharmaceuticals Limited Liability Company [Member]
Takeda Pharmaceuticals Limited Liability Company [Member]
Changes in equity [abstract]
Changes in equity [abstract]
Basic compensation and bonuses
Key management personnel compensation, short-term employee benefits
Security exchange name
Security Exchange Name
Settled and paid during the period
Settled liabilities, contingent liabilities recognised in business combination
Net defined benefit liabilities (assets)
Net defined benefit liabilities (assets)
Balance at beginning of the year
Balance at end of the year
Net defined benefit liability (asset)
Proceeds from long-term loans
Proceeds from non-current borrowings
Financial assets measured at FVTOCI
Financial Assets Measured At Fair Value Through Other Comprehensive Income [Member]
Financial Assets Measured At Fair Value Through Other Comprehensive Income [Member]
Borrowings maturity, term
Borrowings Maturity, Term
Borrowings Maturity, Term
Investments in equity instruments (Note 26)
Investments in equity instruments designated at fair value through other comprehensive income
Disposal of treasury shares
Cancellation of treasury shares
Disposal group name [Domain]
Disposal Group Name [Domain]
[Domain] for Disposal Group Name [Axis]
Summary of Weighted Average Fair Value of Awards at Grant Date
Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]
Beginning balance
Ending balance
Right-of-use assets
Employee service period required for benefits
Defined Benefit Plan, Employee Service Period
Defined Benefit Plan, Employee Service Period
Future Salary Increases
Actuarial assumption of expected rates of salary increases [member]
Contact personnel name
Contact Personnel Name
Acquisition of treasury shares
Acquisition of treasury shares
Purchase of treasury shares
Hedging instrument, liabilities
Hedging instrument, liabilities
Carrying amount – liabilities
Hedging instrument, liabilities
Schedule of Financial Liabilities Not Measured at Fair Value
Financial Liabilities Not Measured At Fair Value [Table Text Block]
Financial Liabilities Not Measured At Fair Value
Other
Loans, Other [Member]
Loans, Other [Member]
No quoted prices in active markets
Level 2 and 3 of fair value hierarchy [member]
0.750% Senior Notes due 2027
0.750% Senior Notes Due 2027 [Member]
0.750% Senior Notes Due 2027
Disclosure of fair value of plan assets [table]
Disclosure of fair value of plan assets [table]
Schedule of Reconciliation of Changes in Provisions
Schedule Of Changes In Provisions [Table Text Block]
Schedule Of Changes In Provisions [Table Text Block]
Schedule of Geographic Information
Disclosure of geographical areas [text block]
Items that may be reclassified subsequently to profit or loss:
Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]
Derivative financial instruments
Derivative financial instruments
Derivatives [member]
Disclosure of reclassifications or changes in presentation [line items]
Disclosure of reclassifications or changes in presentation [line items]
Schedule of Fair Value of Contingent Consideration Classified as Level 3
Fair Value, Liabilities Measured On Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Weighted-average remaining contractual life of share options outstanding
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Statistical Measurement [Domain]
Statistical Measurement [Domain]
Takeda Development Center Americas, Inc.
Takeda Development Center Americas, Inc. [Member]
Takeda Development Center Americas, Inc. [Member]
JPY (millions) Carrying amount
Loans received
Reversal of impairment losses
Reversal of impairment loss recognised in profit or loss, intangible assets other than goodwill
Disclosure of maturity analysis of assets [Line Items]
Disclosure Of Maturity Analysis Of Assets [Line Items]
[Line Items] for Disclosure of maturity analysis of assets [Table]
Expense relating to short-term leases
Expense relating to short-term leases for which recognition exemption has been used
Disposals and other decreases
Disposals, right-of-use assets
Unused tax losses
Unused tax losses [member]
Current service cost
Increase in net defined benefit liability (asset) resulting from current service cost
Exchange differences on translation of foreign operations
Reserve of exchange differences on translation [member]
Liabilities arising from financing activities [axis]
Liabilities arising from financing activities [axis]
Financial assets measured at amortized cost
Financial assets at amortised cost, class [member]
Estimated useful life of intangible asset
Useful life measured as period of time, intangible assets other than goodwill
TAKECAB/VOCINTI
Takecab/Vocinti [Member]
Takecab-F [Member]
Foreign currency translation differences
Increase (Decrease) Through Net Foreign Exchange, Contingent Liabilities Recognised In Business Combination
Increase (Decrease) Through Net Foreign Exchange, Contingent Liabilities Recognised In Business Combination
Classes of share capital [axis]
Classes of share capital [axis]
Exercised (in shares)
Number of share options exercised in share-based payment arrangement
Disclosure of fair value measurement of liabilities [table]
Disclosure of fair value measurement of liabilities [table]
Expense relating to variable lease payments
Expense relating to variable lease payments not included in measurement of lease liabilities
Award vesting percentage
Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Rights, Percentage
Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Rights, Percentage
Non-deductible expenses for tax purposes
Tax effect of expense not deductible in determining taxable profit (tax loss)
Authorized shares as of the beginning of the year
Number of shares authorised
Types of antidilutive instruments [domain]
Types of antidilutive instruments [domain]
Number of instruments that are antidilutive in period presented
Number of instruments that are antidilutive in period presented
Net increase (decrease) in short-term loans and commercial papers
Net increase (decrease) in short-term loans and commercial papers
Proceeds From (Payments For) Short-Term Borrowings
Proceeds From (Payments For) Short-Term Borrowings
Total equity
Equity, as of beginning of period
Equity, as of end of period
Equity
Effect of business combinations and disposals
Increase (decrease) in net defined benefit liability (asset) resulting from business combinations and disposals
Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc. [Member]
Protagonist Therapeutics, Inc.
Entity addresses, address type [Axis]
Entity Addresses, Address Type [Axis]
Share of other comprehensive loss of investments accounted for using the equity method
Share of other comprehensive income of associates and joint ventures accounted for using equity method that will be reclassified to profit or loss, net of tax
Schedule of Other Liabilities
Schedule Of Other Liabilities [Table Text Block]
Schedule Of Other Liabilities [Table Text Block]
2020 EUR Unsecured Senior Notes – fixed rate
Senior Notes 2020 EUR Unsecured Senior Notes Fixed Rate [Member]
Senior Notes 2020 EUR Unsecured Senior Notes Fixed Rate
Disclosure of maturity analysis of assets [Table]
Disclosure Of Maturity Analysis Of Assets [Table]
Disclosure of maturity analysis of assets [Table]
IBI363
IBI363 [Member]
IBI363
Short-term loans
Short-Term Loans
Short-Term Loans
Research and Development Expenses
Description of accounting policy for research and development expense [text block]
Other current liabilities
Current
Other current liabilities
Weighted average duration of defined benefit obligations
Weighted average duration of defined benefit obligation
Equity [Table]
Equity [Table]
Equity [Table]
Before tax effects
Other comprehensive income, before tax, exchange differences on translation of foreign operations
Contract assets
Contract assets [abstract]
Items that will not be reclassified to profit or loss:
Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]
With quoted prices in active markets
Level 1
Level 1 of fair value hierarchy [member]
Contractual commitments for acquisition of pharmaceutical assets
Contractual Commitments For Acquisition Of Pharmaceutical Assets
Contractual Commitments For Acquisition Of Pharmaceutical Assets
Balance in hedge cost reserve
Balance In Hedge Cost Of Exchange Differences On Translation, Continuing Hedges
Balance In Hedge Cost Of Exchange Differences On Translation, Continuing Hedges
Stock options granted (in shares)
Number of share options granted in share-based payment arrangement
Disclosure of detailed information about property, plant and equipment [line items]
Disclosure of detailed information about property, plant and equipment [line items]
VONVENDI
Vonvendi [Member]
Vonvendi
Borrowing availability
Undrawn borrowing facilities
Level 2
Level 2 of fair value hierarchy [member]
Disclosure of non-adjusting events after reporting period [abstract]
Dividends paid
Dividends paid, classified as financing activities
Tools, furniture, and fixtures
Fixtures and fittings [member]
Summary of Payments Made Under the Terms of Collaboration and Licensing Arrangements
Research And Development Arrangement [Table Text Block]
Research And Development Arrangement, Contract To Perform For Others [Table Text Block]
Expiration term
Share-Based Compensation Arrangement By Share-Based Payment Award, Expiration Period
Share-Based Compensation Arrangement By Share-Based Payment Award, Expiration Period
Weighted-average exercise price of share options outstanding (in JPY per share)
As of beginning of the year (in JPY per share)
As of end of the year (in JPY per share)
Weighted average exercise price of share options outstanding in share-based payment arrangement
Owners of the Company
Profit (loss), attributable to owners of parent
Amounts recognized in OCI
Amounts Recognized In OCI [Abstract]
Amounts Recognized In OCI
Settlement
Settlement
Decrease (increase) in net defined benefit liability (asset) resulting from gains (losses) arising from settlements
Financial assets associated with contingent consideration arrangements (Note 26)
Financial Assets Associated With Contingent Consideration Recognised As Of Acquisition Date
Financial Assets Associated With Contingent Consideration Recognised As Of Acquisition Date
Reconciliation of changes in intangible assets and goodwill [abstract]
Reconciliation of changes in intangible assets and goodwill [abstract]
Over 30 days but within 60 days
Later than one month and not later than two months [member]
Major customers [axis]
Major customers [axis]
Assets Held for Sale
Description of accounting policy for non-current assets or disposal groups classified as held for sale [text block]
Takeda Ventures, Inc.
Takeda Ventures, Inc [Member]
Takeda Ventures, Inc
Intangible Assets Other Than Goodwill, Post-Tax
Intangible Assets Other Than Goodwill, Post-Tax [Member]
Intangible Assets Other Than Goodwill, Post-Tax [Member]
Net deferred tax assets
Net deferred tax liabilities, as of beginning of year
Net deferred tax liabilities, as of end of year
Deferred tax liability (asset)
Schedule of Composition of Income Tax Expense (Benefit)
Disclosure Of Major Components Of Tax Expense (Income) [Table Text Block]
Disclosure Of Major Components Of Tax Expense (Income) [Table Text Block]
Total current liabilities
Current liabilities
Cash flow hedges
Derivative hedging instruments
Cash flow hedges [member]
Transfer to liability-settled LTIP (in shares)
Transfer from Equity-Settled LTIP (in shares)
Number Of Share Options Transferred To Liability Settled In Long-Term Incentive Plan, Share-Based Payment Arrangement
Number Of Share Options Transferred To Liability Settled In Long-Term Incentive Plan, Share-Based Payment Arrangement
Others
Other Vaccines [Member]
Other Vaccines
Schedule of Other Financial Assets
Schedule Of Other Financial Assets [Table Text Block]
Schedule Of Other Financial Assets [Table Text Block]
Trade and other receivables [abstract]
Continuing and discontinued operations [axis]
Continuing and discontinued operations [axis]
Inventories
Total
Current inventories
Deferred tax assets
Deferred tax assets
Individual assets or cash-generating units [axis]
Individual assets or cash-generating units [axis]
Non- controlling interests
Non-controlling interests [member]
Non-controlling interests
Comprehensive income, attributable to non-controlling interests
Increase (decrease) in defined benefit obligation due to decrease in assumption
Increase (decrease) in defined benefit obligation due to reasonably possible decrease in actuarial assumption
Document accounting standard
Document Accounting Standard
USD Syndicated Loans
USD Syndicated Loans [Member]
USD Syndicated Loans
Acquisition from conversion of convertible notes
Other Increase (Decrease), Fair Value Measurement, Conversion Of Convertible Notes
Other Increase (Decrease), Fair Value Measurement, Conversion Of Convertible Notes
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Property, plant and equipment
Property, Plant And Equipment Related Temporary Differences [Member]
Property, Plant And Equipment Related Temporary Differences [Member]
Rebates and return reserves
Refunds provision [member]
Disclosure of quantitative information about right-of-use assets [line items]
Disclosure of quantitative information about right-of-use assets [line items]
Share-based Payments
Description of accounting policy for share-based payment transactions [text block]
Statement of changes in equity [abstract]
Statement of changes in equity [abstract]
Retained earnings
Retained earnings
Measurement
Measurement [domain]
Bonds
Debt instruments, amount contributed to fair value of plan assets
List Of Accounting Policies [Abstract]
Significant Accounting Policies [Abstract]
Significant Accounting Policies
Forfeited/expired after vesting (in JPY per share)
Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Weighted Average Exercise Price, Forfeited After Vesting
Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Weighted Average Exercise Price, Forfeited After Vesting
From changes in financial assumptions
Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions
Disclosure of detailed information about financial instruments [line items]
Disclosure of detailed information about financial instruments [line items]
Buildings and structures
Buildings [member]
Change in fair value of financial assets and liabilities associated with contingent consideration arrangements (Note 26)
Decrease In Contingent Liabilities Recognised In Business Combination
Decrease In Contingent Liabilities Recognised In Business Combination
Granted (in shares)
Number of other equity instruments granted in share-based payment arrangement
REPLAGAL
Replagal [Member]
Replagal [Member]
Vesting period
Share-Based Compensation Arrangement By Share-based Payment Award, Award Vesting Period
Share-Based Compensation Arrangement By Share-based Payment Award, Award Vesting Period
Types of risks [domain]
Types of risks [domain]
Takeda Mexico S.A.de C.V.
Takeda Mexico S.A.de C.V. [Member]
Takeda Mexico S.A.de C.V.
Decrease (increase) in trade and other receivables
Adjustments for decrease (increase) in trade and other receivables
Legal Entity [Axis]
Legal Entity [Axis]
Contact personnel fax number
Contact Personnel Fax Number
Derivative financial instruments (Note 26)
Derivative financial assets
Subsidiaries [axis]
Subsidiaries [axis]
Net profit (loss) for the year attributable to owners of the Company JPY (millions)
Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating basic earnings per share
JPY
Japan, Yen
Discount Rate
Actuarial assumption of discount rates [member]
Effect of changes in applicable tax rates and tax law
Tax effect from change in tax rate
From changes in demographic assumptions
Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in demographic assumptions
Takeda France S.A.S.
Takeda France S.A.S. [Member]
Takeda France S.A.S. [Member]
Geographical areas [axis]
Geographical areas [axis]
Net defined benefit liability (asset) [domain]
Net defined benefit liability (asset) [domain]
Acquisition of shares in associates
Purchase of interests in associates
Beginning balance
Ending balance
Liabilities arising from financing activities
Before tax effects
Share of other comprehensive income of associates and joint ventures accounted for using equity method, before tax
Entity common stock, shares outstanding (in shares)
Entity Common Stock, Shares Outstanding
ADCETRIS
Adcetris [Member]
Adcetris [Member]
Intangible assets
Beginning balance
Ending balance
Intangible assets
Intangible assets other than goodwill
Document Financial Statement Error Correction [Flag]
Document Financial Statement Error Correction [Flag]
Liability-settled long-term incentive plan (LTIP)
Liability-Settled Long-Term Incentive Plan [Member]
Liability-Settled Long-Term Incentive Plan
Disposals and other decreases
Disposals, intangible assets other than goodwill
Changes in the fair value during the period
Increase (Decrease) Through Fair Value Measurement, Contingent Liabilities Recognised In Business Combination
Increase (Decrease) Through Fair Value Measurement, Contingent Liabilities Recognised In Business Combination
Cash and cash equivalents
Cash and cash equivalents at the beginning of the year
Cash and cash equivalents at the end of the year (Consolidated statements of financial position)
Total
Cash and cash equivalents
Classes of ordinary shares [axis]
Classes of ordinary shares [axis]
Document Information [Table]
Document Information [Table]
Other
Other Financial Assets, Miscellaneous
Other Financial Assets, Miscellaneous
ICLUSIG
Iclusig [Member]
Iclusig [Member]
Joint operations [axis]
Joint operations [axis]
McKesson Group
McKesson Corporation [Member]
McKesson Corporation [Member]
Schedule of Transactions between Related Parties
Disclosure of transactions between related parties [text block]
Total liabilities and equity
Equity and liabilities
U.S.
UNITED STATES
Others
Other Oncology [Member]
Other Oncology [Member]
Foreign currency translation differences
Increase (decrease) through net exchange differences, other provisions
Business combinations [axis]
Business combinations [axis]
Total
Beginning balance
Ending balance
Provisions
Provisions
Research And Development [Abstract]
Collaborations, Licensing Arrangements, Other Asset Acquisitions, and Others [Abstract]
Collaborations, Licensing Arrangements, Other Asset Acquisitions, and Others
Other
Other Financial Liabilities, Miscellaneous
Other Financial Liabilities, Miscellaneous
Foreign currency denominated bonds and loans
Foreign Currency Denominated Bonds And Loans [Member]
Foreign Currency Denominated Bonds And Loans [Member]
Business combinations
Business combinations [domain]
Interests In Other Entities [Abstract]
Interests In Other Entities [Abstract]
Interests In Other Entities [Abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Disclosure of analysis of single amount of discontinued operations [line items]
Cross currency interest rate swaps
Cross currency interest rate swaps
Cross Currency Interest Rate Swap [Member]
Cross Currency Interest Rate Swap
Long-term loans
Long-term borrowings [member]
Contract liabilities
Transaction price allocated to remaining performance obligations
Gains on derivatives
Gains on change in fair value of derivatives
ALUNBRIG
Alunbrig [Member]
Alunbrig [Member]
Joint operations [domain]
Joint operations [domain]
Change in fair value of financial assets and liabilities associated with contingent consideration arrangements (Note 26)
Increase In Contingent Liabilities Recognised In Business Combination
Increase In Contingent Liabilities Recognised In Business Combination
Schedule of Non-Derivative Financial Liabilities by Maturity
Disclosure of maturity analysis for non-derivative financial liabilities [text block]
Foreign exchange movement
Increase (decrease) through effect of changes in foreign exchange rates, liabilities arising from financing activities
Interest risk
Interest rate risk [member]
City area code
City Area Code
Changes in fair value of financial assets measured at fair value through OCI:
Financial Assets Measured At Fair Value Through Other Comprehensive Income, Reclassified to Profit Or Loss [Abstract]
Financial Assets Measured At Fair Value Through Other Comprehensive Income, Reclassified to Profit Or Loss
United States Dollar
United States of America, Dollars
Long-term loans
Long-Term Loans [Member]
Long-Term Loans [Member]
Disclosure of net defined benefit liability (asset) [table]
Disclosure of net defined benefit liability (asset) [table]
Total dividend income
Dividend income
Directors
Nonemployee, Share Based Payment Arrangement [Member]
Nonemployee, Share Based Payment Arrangement
Estimated useful life of major asset items
Useful life measured as period of time, property, plant and equipment
Settlement of forward exchange contracts, net
Settlement of forward exchange contracts, net
Cash Payments For Forward Exchange Contracts, Net, Classified As Operating Activities
Cash Payments For Forward Exchange Contracts, Net, Classified As Operating Activities
Total expenses not included in lease liabilities
Expenses Not Included In Lease Liabilities
Expenses Not Included In Lease Liabilities
AMITIZA Antitrust Litigation
AMITIZA Antitrust Litigation [Member]
AMITIZA Antitrust Litigation
Categories of financial liabilities
Categories of financial liabilities [domain]
Transfers from other components of equity
Increase (decrease) through other changes, equity
More than five years
After 5th year
More than five years
Later than five years [member]
Related Party Transactions
Disclosure of related party [text block]
Classes of financial assets
Classes of financial assets [domain]
Intangible Assets
Disclosure of intangible assets [text block]
Other financial liabilities
Financial liabilities at amortised cost, class [member]
Compliance with International Financial Reporting Standards
Statement of IFRS compliance [text block]
Interest rate swaps
Interest rate swap contract [member]
Level 3
Level 3 of fair value hierarchy [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [table]
Disclosure of reconciliation of changes in intangible assets and goodwill [table]
Recognized in other comprehensive income
Income tax relating to components of other comprehensive income
Takeda GmbH
Takeda GmbH [Member]
Takeda GmbH [Member]
Disclosure of transaction price allocated to remaining performance obligations [table]
Disclosure of transaction price allocated to remaining performance obligations [table]
Interest expense on lease liabilities
Interest expense on lease liabilities
Use of Judgments, Estimates, and Assumptions
Disclosure of accounting judgements and estimates [text block]
Total
Trade and other payables
Repayments of non-current borrowings
Repayments of non-current borrowings
Auditor Name
Auditor Name
Restricted stock units (RSUs)
Restricted Stock Units [Member]
Restricted Stock Units [Member]
Decreases (written off)
Decrease through write-off, financial assets
Finance Income:
Finance Income [Abstract]
Finance Income [Abstract]
Trade and Other Receivables
Disclosure of trade and other receivables [text block]
US state law change
US State Law Change [Member]
US State Law Change
DEXILANT
Dexilant [Member]
Dexilant [Member]
Total transactions with owners
Increase (decrease) through transactions with owners, equity
Total liabilities
Disposal Group, Including Discontinued Operation, Liabilities
Disposal Group, Including Discontinued Operation, Liabilities
Past due status [axis]
Past due status [axis]
Goodwill
Goodwill [member]
ADYNOVATE/ADYNOVI
Adynovate/Adynovi [Member]
Adynovate [Member]
Schedule of Transaction Price Allocated to the Remaining Performance Obligations
Disclosure of transaction price allocated to remaining performance obligations [text block]
Disclosure of major customers [line items]
Disclosure of major customers [line items]
Net cash from operating activities
Cash flows from (used in) operating activities
Finished products and merchandise
Current finished goods
Forfeited/expired before vesting (in shares)
Number of other equity instruments forfeited in share-based payment arrangement
Disclosure of terms and conditions of share-based payment arrangement [line items]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Current tax expense (income), related to Pillar Two income taxes
Current tax expense (income), related to Pillar Two income taxes
Subsidiaries and Associates
Disclosure of interests in other entities [text block]
Corporate officers and senior management
Employee, Share Based Payment Arrangement [Member]
Employee, Share Based Payment Arrangement
Non-current liabilities:
Non-current liabilities [abstract]
Entity [Domain]
Entity [Domain]
Share-based Payments
Disclosure of share-based payment arrangements [text block]
Other
Miscellaneous other operating income
Other financial liabilities
Non-current
Other non-current financial liabilities
Disclosure of maturity analysis for financial liabilities [Table]
Disclosure Of Maturity Analysis For Financial Liabilities [Table]
Disclosure of maturity analysis for financial liabilities [Table]
Deferred income
Deferred income including contract liabilities
Derivative hedging instruments
Financial Liabilities At Fair Value Through Derivative Hedging Instruments [Member]
Financial Liabilities at Fair Value Through Derivative Hedging Instruments [Member]
Document fiscal year focus
Document Fiscal Year Focus
Liabilities from share-based payment transactions
Liabilities from share-based payment transactions
Changes in assets and liabilities:
Adjustments to reconcile profit (loss) [abstract]
Financial liabilities associated with programs to sell certain receivables
Financial Liabilities, Programs To Sell Certain Receivables
Financial Liabilities, Programs To Sell Certain Receivables
Contract amount to be settled in more than one year
Over one year
Later than one year [member]
Reclassification adjustments to profit or (loss)
Reclassification Adjustments On Hedging Cost, Before Tax
Reclassification Adjustments On Hedging Cost, Before Tax
2.000% Senior Notes due 2040
2.000% Senior Notes Due 2040 [Member]
2.000% Senior Notes Due 2040
Net defined benefit liabilities
Non-current net defined benefit liability
Cash flow hedge
Hedge Gain (Loss) [Member]
Hedge Gain (Loss) [Member]
Grantee Status [Axis]
Share-Based Payment Arrangement, Grantee Status [Axis]
Grantee Status [Axis]
Acquisition of shares of collaboration and in-licensing partners
Payments For Shares Of Collaboration And In-Licensing Partners
Payments For Shares Of Collaboration And In-Licensing Partners
Types of interest rates [domain]
Types of interest rates [domain]
Lease liabilities
Lease liabilities
Finance Lease Liability [Member]
Finance Lease Liability [Member]
Interest income from financial assets measured at fair value through P&L
Interest income on financial assets designated at fair value through profit or loss
Life insurance company general accounts
Life Insurance Company General Accounts, Amount Contributed To Fair Value Of Plan Assets
Life Insurance Company General Accounts, Amount Contributed To Fair Value Of Plan Assets
Other operating income
Total
Other income
Classes of other provisions [axis]
Classes of other provisions [axis]
Estimated future cash flows, projection period
Estimated Future Cash Flows, Projection Period
Estimated Future Cash Flows, Projection Period
Schedule of Composition of Debt Instruments
Disclosure of debt instruments [text block]
New Accounting Standards and Interpretations Adopted and Issued ans Not Yet Adopted
Disclosure of expected impact of initial application of new standards or interpretations [text block]
Disclosure Of Financial Assets And Liabilities [Table]
Disclosure Of Financial Assets And Liabilities [Table]
Disclosure of financial assets and liabilities [Table]
Aggregate provisions for legal and other disputes
Legal proceedings provision
Baxalta Manufacturing S.à r.l.
Baxalta Manufacturing S.a r.l. [Member]
Baxalta Manufacturing S.à r.l. [Member]
Exchange [Domain]
Exchange [Domain]
Japan Government Bond Interest Rate
Japan Government Bond Interest Rate [Member]
Japan Government Bond Interest Rate
Total
Key management personnel compensation
Shares issued:
Number of shares issued [abstract]
Other
Other finance cost
Derivative financial instruments (Note 26)
Derivative financial liabilities
Summary of Significant Actuarial Assumptions Used to Determine Present Value
Disclosure of defined benefit plans [text block]
Baxalta Belgium Manufacturing S.A.
Baxalta Belgium Manufacturing S.A. [Member]
Baxalta Belgium Manufacturing S.A.
NINLARO
Ninlaro [Member]
Ninlaro [Member]
Ordinary shares
Ordinary shares [member]
Trade receivables
Current trade receivables
Summary of Increase (Decrease) in Loss Allowance for Trade Receivables
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [text block]
Liabilities held for sale
Liabilities included in disposal groups classified as held for sale
Equity interest type [Domain]
Equity Interest Type [Domain]
[Domain] for Equity Interest Type [Axis]
Earnings per Share
Disclosure of earnings per share [text block]
Acquisition cost
Acquisition cost of ROU Assets
Gross carrying amount [member]
Trade and other payables
Trade and other current payables
Applicable tax rate
Applicable tax rate
Inventories
Disclosure of inventories [text block]
Decrease in other financial liabilities
Adjustments for increase (decrease) in other liabilities
Local phone number
Local Phone Number
Post trial access cost
Other Operating Expense, Post Trial Access Cost
Other Operating Expense, Post Trial Access Cost
Within one year
1st year
Contract amount
Not later than one year [member]
AMITIZA Antitrust Litigation, Wholesaler Class
AMITIZA Antitrust Litigation, Wholesaler Class [Member]
AMITIZA Antitrust Litigation, Wholesaler Class
Disclosure of detailed information about property, plant and equipment [abstract]
Disclosure of detailed information about property, plant and equipment [abstract]
Schedule of Trade and Other Receivables
Schedule Of Accounts, Notes, Loans And Financing Receivable [Table Text Block]
Schedule Of Accounts, Notes, Loans And Financing Receivable [Table Text Block]
Other comprehensive income associated with assets held for sale
Amount recognised in other comprehensive income and accumulated in equity relating to non-current assets or disposal groups held for sale
Measured at fair value through profit or loss
Financial liabilities at fair value through profit or loss, category [member]
Other
Restructuring, Other [Member]
Other Restructuring [Member]
Bonds and loans
Non-current
Non-current portion of non-current borrowings
Increase in inventories
Adjustments for decrease (increase) in inventories
Disclosure of financial assets [line items]
Disclosure of financial assets [line items]
Other
Other Operating Expense
Other Operating Expense
Property, Plant and Equipment
Description of accounting policy for property, plant and equipment [text block]
Investment, name [Axis]
Investment, Name [Axis]
Proceeds from issuance of bonds and long-term loans
Proceeds from borrowings, classified as financing activities
Exercise of share-based awards
Increase (Decrease) Through Exercise Of Share-Based Payment Transactions
Increase (Decrease) Through Exercise Of Share-Based Payment Transactions
Repayments of lease liabilities
Payments of lease liabilities, classified as financing activities
Other components of equity
Other Components Of Equity
Other Components Of Equity
Entity voluntary filers
Entity Voluntary Filers
Share of loss (profit) of investments accounted for using the equity method
Adjustments for undistributed profits of investments accounted for using equity method
Impairment loss recognised in profit or loss
Increases
Impairment loss recognised in profit or loss
Business Combinations
Disclosure of business combinations [text block]
Derivative hedging instruments
Financial Assets At Fair Value Through Derivative Hedging Instruments [Member]
Financial Assets At Fair Value Through Derivative Hedging Instruments [Member]
Change in fair value
Increase (decrease) through changes in fair values, liabilities arising from financing activities
Disposal group name [Axis]
Disposal Group Name [Axis]
Disposal Group Name [Axis]
Loss on derivatives – Virtual power purchase agreement
Losses on change in fair value of derivatives
Reserve of exchange differences on translation, continuing hedges
Reserve of exchange differences on translation, continuing hedges
ADDERALL XR
Adderall XR [Member]
Adderall XR
Entity registrant name
Entity Registrant Name
Raw materials and supplies
Current raw materials
Basic earnings (loss) per share (in JPY per share)
Basic earnings per share (in JPY per share)
Basic earnings (loss) per share
Benefits paid
Benefits paid
Decrease (increase) in net defined benefit liability (asset) resulting from payments in respect of settlements
Measurement [axis]
Measurement [axis]
Number of immaterial subsidiaries
Number Of Immaterial Subsidiaries
Number Of Immaterial Subsidiaries
Weighted-average number of ordinary shares outstanding during the year (diluted) (in shares)
Weighted average number of ordinary shares used in calculating diluted earnings per share
New York Stock Exchange
NEW YORK STOCK EXCHANGE, INC. [Member]
Restructuring Type [Domain]
Restructuring Type [Domain]
[Domain] for Restructuring Type [Axis]
Trade receivables (Note 16)
Current receivables from contracts with customers
Schedule of Expenses Related to Leases Not Included in the Measurement of the Lease Liabilities
Disclosure of additional information about leasing activities for lessee [text block]
Equities
Equity instruments, amount contributed to fair value of plan assets
Deferred tax expense (income) relating to origination and reversal of temporary differences
Deferred tax expense (income) relating to origination and reversal of temporary differences
Revision of Prior Period [Domain]
Revision of Prior Period [Domain]
Classes of intangible assets other than goodwill [domain]
Classes of intangible assets other than goodwill [domain]
Takeda Pharmaceuticals Korea Co., Ltd.
Takeda Pharmaceuticals Korea Co., Ltd. [Member]
Takeda Pharmaceuticals Korea Co., Ltd. [Member]
Other assets
Disposal Group, Including Discontinued Operation, Other Assets1
Disposal Group, Including Discontinued Operation, Other Assets1
Takeda Distribuidora Ltda.
Takeda Distribuidora Ltda. [Member]
Takeda Distribuidora Ltda. [Member]
Interest Rate And Currency Swap Netting
Interest Rate And Currency Swap Netting [Member]
Interest Rate And Currency Swap Netting
Remeasurement of defined benefit pension plans:
Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans [abstract]
Other payables
Other payables
1.375% Senior Notes due 2032
1.375% Senior Notes Due 2032 [Member]
1.375% Senior Notes Due 2032
Classes of intangible assets and goodwill [axis]
Classes of intangible assets and goodwill [axis]
Additional potential payment, regulatory approval milestones
Additional Potential Payment, Regulatory Approval Milestones
Additional Potential Payment, Regulatory Approval Milestones
Non-controlling interests
Non-controlling interests
Debt securities
Investments in debt instruments
Debt securities [member]
Gain on divestment of business and subsidiaries (Note 18)
Gain On Sale Of Interests In Subsidiary
Gain On Sale Of Interests In Subsidiary
Amounts arising during the year
Gains (losses) on financial assets measured at fair value through other comprehensive income, before tax
Employee Benefits
Disclosure of employee benefits [text block]
Schedule of Reconciliation of Changes in Goodwill
Schedule of Reconciliation of Changes in Intangible Assets
Disclosure of reconciliation of changes in intangible assets and goodwill [text block]
Non-controlling interests
Profit (loss), attributable to non-controlling interests
All Currencies [Domain]
All Currencies [Domain]
Equity:
Equity [abstract]
Disclosure of operating segments [abstract]
Previously Reported
Previously Reported [Member]
Schedule of Fair Value Measurement of Assets
Disclosure of fair value measurement of assets [text block]
Subclassifications of assets, liabilities and equities [abstract]
Subclassifications of assets, liabilities and equities [abstract]
Foreign currency translation differences
Foreign currency translation differences
Increase (decrease) in net defined benefit liability (asset) resulting from changes in foreign exchange rates, net defined benefit liability (asset)
Weighted average fair value at grant date
Weighted average fair value at measurement date, share options granted
Hedging instruments [axis]
Hedging instruments [axis]
Changes in fair value of financial assets measured at fair value through OCI
Other comprehensive income, net of tax, financial assets measured at fair value through other comprehensive income
Additions and other increases
Additions other than through business combinations, intangible assets other than goodwill
Disclosure of fair value measurement of liabilities [line items]
Disclosure of fair value measurement of liabilities [line items]
Measured at fair value through other comprehensive income
Financial assets at fair value through other comprehensive income, category [member]
Disclosure of reclassifications or changes in presentation [table]
Disclosure of reclassifications or changes in presentation [table]
2018 USD Unsecured Senior Notes – fixed rate
Senior Notes 2018 USD Fixed Rate [Member]
Senior Notes 2018 USD Fixed Rate [Member]
ICFR auditor attestation flag
ICFR Auditor Attestation Flag
Schedule of Changes in Fair Value of Plan Assets and Breakdown by Asset Class
Disclosure of fair value of plan assets [text block]
Schedule of Restructuring Expenses
Restructuring And Related Costs [Table Text Block]
Restructuring and Related Costs [Table Text Block]
Tianjin Takeda Pharmaceuticals Co., Ltd.
Tianjin Takeda Pharmaceuticals Co., Ltd [Member]
Tianjin Takeda Pharmaceuticals Co., Ltd
Increases
Increase in existing provisions, other provisions
Disclosure of temporary difference, unused tax losses and unused tax credits [table]
Disclosure of temporary difference, unused tax losses and unused tax credits [table]
Unsecured Senior Notes Assumed in Shire Acquisition
Unsecured Senior Notes Due September 2023 To September 2026 [Member]
Unsecured Senior Notes Due September 2019 To September 2026 [Member]
Temporary differences associated with investments in subsidiaries, branches and associates and interests in joint arrangements for which deferred tax assets have not been recognised
Temporary Differences Associated With Investments In Subsidiaries, Branches And Associates And Interests In Joint Arrangements For Which Deferred Tax Assets Have Not Been Recognised
Temporary Differences Associated With Investments In Subsidiaries, Branches And Associates And Interests In Joint Arrangements For Which Deferred Tax Assets Have Not Been Recognised
Cash outflow for leases
Cash outflow for leases
Litigation Case [Axis]
Litigation Case [Axis]
Restructuring
Restructuring provision [member]
Impairment losses
Impairment loss
Auditor Firm ID
Auditor Firm ID
Other
Key management personnel compensation, post-employment benefits
Share premium
Share premium [member]
Number of company’s consolidated subsidiaries
Number Of Company’s Consolidated Subsidiaries
Number Of Company’s Consolidated Subsidiaries
Owners of the Company
Comprehensive income, attributable to owners of parent
Tax effects
Income Tax Relating To Hedging Cost Included In Other Comprehensive Income
Income Tax Relating To Hedging Cost Included In Other Comprehensive Income
Cumulative gain on equity investments reclassified from other comprehensive income to retained earnings upon disposal
Cumulative gain (loss) on disposal of investments in equity instruments designated at fair value through other comprehensive income
Bilateral Loans
Bilateral Loans [Member]
Bilateral Loans
Total liabilities
Liabilities
Liabilities
Government Grants
Description of accounting policy for government grants [text block]
GATTEX/REVESTIVE
Gattex/Revestive [Member]
Gattex/Revestive [Member]
Disclosure of subsidiaries [table]
Disclosure of subsidiaries [table]
FEIBA
Feiba [Member]
FEIBA [Member]
Schedule of Derivative Financial Liabilities by Maturity
Disclosure of maturity analysis for derivative financial liabilities [text block]
Disclosure of net defined benefit liability (asset) [line items]
Disclosure of net defined benefit liability (asset) [line items]
Income taxes payable
Current tax liabilities, current
Accrued expenses
Accrued Expenses
Accrued Expenses
QDENGA
Qdenga [Member]
Qdenga
Intangible Assets Associated with Products and Intangible Assets – Software
Description of accounting policy for intangible assets other than goodwill [text block]
LIVTENCITY
Livtencity [Member]
Livtencity
Discount rate (post-tax)
Discount rate applied to cash flow projections
Foreign currency translation differences
Increase (decrease) through net exchange differences, property, plant and equipment
Disclosure of fair value of plan assets [line items]
Disclosure of fair value of plan assets [line items]
Virtual power purchase agreement
Virtual Power Purchase Agreement [Member]
Virtual Power Purchase Agreement
Property, plant and equipment
Disposal Group, Including Discontinued Operation, Assets, Property, Plant And Equipment
Disposal Group, Including Discontinued Operation, Assets, Property, Plant And Equipment
VYVANSE/ELVANSE
Vyvanse/Elvanse [Member]
Vyvanse/Elvanse
Forward exchange contracts, selling
Forward Exchange Contract, Selling [Member]
Forward Exchange Contract, Selling [Member]
Amounts arising during the year
Other Comprehensive Income, Gains (Losses) Hedging Cost, Before Tax
Other Comprehensive Income, Gains (Losses) Hedging Cost, Before Tax
Finance (income) and expenses, net
Adjustments for finance income (cost)
Effect of prior year items
Tax Effect Of Prior Year Items In Determining Taxable Profit (Loss)
Tax Effect Of Prior Year Items In Determining Taxable Profit (Loss)
Takeda APAC Biopharmaceutical Research and Development Co., Ltd.
Takeda APAC Biopharmaceutical Research and Development Co,. Ltd. [Member]
Takeda APAC Biopharmaceutical Research and Development Co,. Ltd.
Amounts arising during the year
Other comprehensive income, before tax, gains (losses) from investments in equity instruments
Property, plant and equipment
Beginning of period
Ending of period
Property, plant and equipment including right-of-use assets
Fair value
Financial liabilities, at fair value
Financial liabilities, at fair value
Current tax expense
Current tax expense (income)
Equity-settled share-based compensation
Expense from equity-settled share-based payment transactions
Hedging instruments
Hedging instruments [domain]
Non-adjusting events after reporting period [axis]
Non-adjusting events after reporting period [axis]
Restructuring expenses (Note 22)
Total
Restructuring And Impairment Loss
Restructuring And Impairment Loss
Between one and five years
Less than 5 years
Later than one year and not later than five years [member]
Continuing operations, unless line item indicates otherwise [member]
Continuing operations, unless line item indicates otherwise [member]
Dilutive effect (in shares)
Dilutive Effect On Number Of Ordinary Shares
Dilutive Effect On Number Of Ordinary Shares
Top of range
Top of range [member]
Non-Cash:
Non-Cash [Abstract]
Non-Cash
Earnings per share [line items]
Earnings per share [line items]
Intangible assets and goodwill [abstract]
Intangible assets and goodwill [abstract]
Settlement of cross currency interest swaps related to bonds and loans
Proceeds From The Settlement Of Swaps
Proceeds From The Settlement Of Swaps
In-process R&D
Research And Development, In-Process [Member]
In-Process Research And Development [Member]
Research and development expenses
Research and development expense
Scenario [Axis]
Scenario [Axis]
Other non-current assets
Other non-current assets
Legal proceedings provision
Legal proceedings provision [member]
Valuation reserve for pre-launch inventories (reversal)
Valuation Reserve For Pre-Launch Inventories (Reversal) Expense
Valuation Reserve For Pre-Launch Inventories (Reversal) Expense
Takeda Pharma Ltda.
Takeda Pharma Ltda. [Member]
Takeda Pharma Ltda.
4th year
Between three and four years
Later than three years and not later than four years [member]
Scheude of Components of Other Comprehensive Income (Loss)
Condensed Statement of Comprehensive Income [Table Text Block]
Remeasurement of defined benefit pension plans
Remeasurement of defined benefit pension plans
Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans
Dividends received from associates, classified as investing activities
Dividends received from associates, classified as investing activities
Tax credits
Unused tax credits [member]
AMITIZA Antitrust Litigation, Individual Retailers
AMITIZA Antitrust Litigation, Individual Retailers [Member]
AMITIZA Antitrust Litigation, Individual Retailers
Other comprehensive income that will not be reclassified to profit or loss, net of tax
Other comprehensive income that will not be reclassified to profit or loss, net of tax
Other operating expenses
Total
Miscellaneous other operating expense
Cash and cash equivalent
Cash and cash equivalents, amount contributed to fair value of plan assets
Transfers from investments accounted for using the equity method
Transfers From Investments, Equity Method
Transfers From Investments, Equity Method
Foreign
Foreign countries [member]
Assets and liabilities classified as held for sale [axis]
Assets and liabilities classified as held for sale [axis]
Inventories
Description of accounting policy for measuring inventories [text block]
Non-current assets
Non-current assets other than financial instruments, deferred tax assets, post-employment benefit assets, and rights arising under insurance contracts
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]
Plan name [Axis]
Plan Name1 [Axis]
Plan Name [Axis]
Forfeited/expired after vesting (in shares)
Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Forfeited After Vesting
Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Forfeited After Vesting
Borrowings by name [domain]
Borrowings by name [domain]
Summary of Major Employee Benefits Expenses other than Retirement Benefits
Disclosure Of Other Employee Benefit Costs [Table Text Block]
Disclosure Of Other Employee Benefit Costs [Table Text Block]
Present value of defined benefit obligations
At beginning of the year
At end of the year
Defined benefit obligation, at present value
Over 60 days but within 90 days
Later than two months and not later than three months [member]
Currency risk
Currency risk [member]
Trade and other receivables
Trade receivables [member]
Revenue from contracts with customers
Revenue from contracts with customers
Summary of Amounts Related to Defined Benefit Pension Plans Recognized in Consolidated Statements of Financial Position
Disclosure Of Defined Benefit Plan Expense Recognized In Financial Position Explanatory [Table Text Block]
Disclosure Of Defined Benefit Plan Expense Recognized In Financial Position Explanatory
Functional and Presentation Currency
Description of accounting policy for functional currency [text block]
Foreign currency translation differences
Increase (decrease) through foreign exchange, financial assets
TAKHZYRO
Takhzyro [Member]
Takhzyro [Member]
Tax effects
Income tax relating to share of other comprehensive income of associates and joint ventures accounted for using equity method
Baxalta Innovations GmbH
Baxalta Innovations GmbH [Member]
Baxalta Innovations GmbH [Member]
Deferred tax liabilities
Deferred tax liabilities
Deferred tax liabilities
Other comprehensive income (loss) for the year, net of tax
Other comprehensive income (loss)
Other comprehensive income
Classes of liabilities [axis]
Classes of liabilities [axis]
Transfers to Level 1
Transfers out of Level 3 of fair value hierarchy, assets
Counterparties [domain]
Counterparties [domain]
Other
Other Countries Not Separately Reported [Member]
Other Countries Not Separately Reported [Member]
Treasury shares
Treasury shares [member]
Amount past due
Past due status [domain]
Net increase (decrease) in cash and cash equivalents
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
Types of share-based payment arrangements [axis]
Types of share-based payment arrangements [axis]
Forecast
Forecast [Member]
DEXILANT Antitrust Litigation
DEXILANT Antitrust Litigation [Member]
DEXILANT Antitrust Litigation
Title of 12(b) security
Title of 12(b) Security
Disclosure of subsidiaries [line items]
Disclosure of subsidiaries [line items]
Schedule of Fair Value Measurement of Liabilities
Disclosure of fair value measurement of liabilities [text block]
Additional potential payment, cumulative sales milestones
Additional Potential Payment, Cumulative Sales Milestones
Additional Potential Payment, Cumulative Sales Milestones
Issuance of new shares
Issue of equity
Issue of equity
Principal amount in contractual currency (millions)
Bank borrowings, undiscounted cash flows
Net defined benefit asset
Net defined benefit asset
EOHILIA
Eohilia [Member]
Eohilia
Hedged items [domain]
Hedged items [domain]
Defined benefit plans
Defined Benefit Plan Related Temporary Differences [Member]
Defined Benefit Plan Related Temporary Differences [Member]
Bonuses
Employee Bonuses
Employee Bonuses
Takeda UK Limited
Takeda UK Limited [Member]
Takeda UK Limited [Member]
Takeda (China) International Trading Co., Ltd.
Takeda (China) International Trading Co., Ltd. [Member]
Takeda (China) International Trading Co., Ltd.
Disclosure Of Financial Assets And Liabilities [Line Items]
Disclosure Of Financial Assets And Liabilities [Line Items]
[Line Items] for Disclosure of financial assets and liabilities [Table]
Schedule of Other Operating Income and Expenses
Disclosure Of Other Operating Income (Expense) Explanatory [Table Text Block]
Disclosure Of Other Operating Income (Expense) Explanatory [Table Text Block]
Treasury Shares
Description of accounting policy for treasury shares [text block]
Profit (loss) before tax
Accounting profit
Blackstone Life Sciences, BXLS
Blackstone Life Sciences, BXLS [Member]
Blackstone Life Sciences, BXLS
Cross currency interest rate swaps
Hedge related to acquisition
Currency swap contract [member]
Decrease in number of entities accounted for using the equity method due to a change of ownership ratio
Decrease In Number Of Entities Accounted For Using The Equity Method Due To Changes Of Ownership Ratio
Decrease In Number Of Entities Accounted For Using The Equity Method Due To Changes Of Ownership Ratio
Schedule of Shares Activity
Disclosure of issued capital [text block]
Subsidiaries [domain]
Subsidiaries [domain]
Repayments of bonds and long-term loans
Repayments of borrowings, classified as financing activities
Other
Miscellaneous other provisions [member]
Borrowings by name [axis]
Borrowings by name [axis]
Other financial assets
Current
Current financial assets
EXKIVITY
Exkivity [Member]
Exkivity
Europe and Canada
Europe And Canada [Member]
Europe And Canada [Member]
Trade and Other Payables
Disclosure of trade and other payables [text block]
Disclosure of detailed information about hedging instruments [table]
Disclosure of detailed information about hedging instruments [table]
Accumulated impairment losses
Impairment loss allowance
Accumulated impairment [member]
Financial assets associated with contingent consideration arrangements
Contingent Consideration Asset [Member]
Contingent Consideration Asset [Member]
Chargebacks and other allowances
Chargebacks And Other Allowances
Chargebacks And Other Allowances
Financial Instruments
Disclosure of financial instruments [text block]
FOSRENOL
Fosrenol [Member]
Fosrenol
Financial Instruments [Abstract]
Financial Instruments [Abstract]
Financial Instruments [Abstract]
Schedule of Reconciliation of Changes in Property, Plant and Equipment and Impairment Losses
Disclosure of detailed information about property, plant and equipment [text block]
Classes of intangible assets and goodwill [domain]
Classes of intangible assets and goodwill [domain]
Hedging instrument, assets
Carrying amount – assets
Hedging instrument, assets
Interest rate (%)
Borrowings, interest rate
Net cash used in investing activities
Cash flows from (used in) investing activities
Schedule of Derivative Assets and Liabilities
Disclosure of derivative financial instruments [text block]
Disclosure of detailed information about intangible assets [line items]
Disclosure of detailed information about intangible assets [line items]
Other financial assets
Non-current
Non-current financial assets
General Information About Financial Statements [Abstract]
General Information About Financial Statements [Abstract]
General Information About Financial Statements [Abstract]
Intangible assets associated with products
Product-Related Intangible Assets [Member]
Product-Related Intangible Assets [Member]
Amortization and impairment losses on intangible assets associated with products
Amortization
Amortisation, intangible assets other than goodwill
Financial Instruments
Description of accounting policy for financial instruments [text block]
Total current assets
Current assets
Commercial Paper
Commercial Paper, Debt [Member]
Commercial Paper, Debt
Repayments of lease liabilities
Repayment Of Lease Liability
Repayment Of Lease Liability
Tax effect of changes in unrecognized deferred tax assets, deferred tax expense related to interest expense carryforward
Tax Effect Of Changes In Unrecognized Deferred Tax Assets, Deferred Tax Expense Related To Interest Expense Carryforward
Tax Effect Of Changes In Unrecognized Deferred Tax Assets, Deferred Tax Expense Related To Interest Expense Carryforward
Reclassification adjustments to profit or (loss)
Reclassification adjustments on exchange differences on translation of foreign operations, before tax
Share options
Share options [member]
Takeda Pharmaceuticals International AG
Takeda Pharmaceuticals International AG [Member]
Takeda Pharmaceuticals International AG [Member]
Recognized in profit or (loss)
Deferred tax expense (income) recognised in profit or loss
Recognition of financial assets associated with contingent consideration arrangements
Fair Value, Recognition Of Financial Assets Associated With Contingent Consideration Arrangements
Fair Value, Recognition Of Financial Assets Associated With Contingent Consideration Arrangements
Deferred income
Deferred Income Related Temporary Differences [Member]
Deferred Income Related Temporary Differences [Member]
Types of risks [axis]
Types of risks [axis]
Income taxes payable
Current tax liabilities, non-current
ENTYVIO
Entyvio [Member]
Entyvio [Member]
Trade and other payables [abstract]
Share of other comprehensive loss of investments accounted for using the equity method:
Share of other comprehensive income of associates and joint ventures accounted for using equity method, net of tax [abstract]
Compensation Related Costs [Abstract]
Employee Benefits [Abstract]
Employee Benefits
Depreciation expenses
Depreciation, property, plant and equipment
Types of hedges [axis]
Types of hedges [axis]
AbbVie Supply Agreement Litigation
AbbVie Supply Agreement Litigation [Member]
AbbVie Supply Agreement Litigation
Others
Other Neuroscience [Member]
Other Neuroscience [Member]
Exercised (in JPY per share)
Weighted average exercise price of share options exercised in share-based payment arrangement
Income taxes receivable
Current tax assets, current
Income taxes paid (refund) [abstract]
Trade and other payables
Disposal Group, Including Discontinued Operation, Trade And Other Payables
Disposal Group, Including Discontinued Operation, Trade And Other Payables
Between three and five years
Later than three years and not later than five years [member]
Property, Plant and Equipment
Disclosure of property, plant and equipment [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Stock options
Share-Based Payment Arrangement, Option [Member]
Share-Based Payment Arrangement, Option [Member]
ESOP and BIP Trust
Employee Stock Ownership Plan Trust And Board Incentive Plan Trust [Member]
Employee Stock Ownership Plan Trust And Board Incentive Plan Trust [Member]
Number of associates
Number Of Associates Accounted For Using The Equity Method
Number Of Associates Accounted For Using The Equity Method
Defined Benefit Plan, Change in Benefit Liability [Roll Forward]
Defined Benefit Plan, Change In Benefit Liability [Roll Forward]
Defined Benefit Plan, Change in Benefit Liability [Roll Forward]
Defined contribution costs
Post-employment benefit expense, defined contribution plans
Impairment of assets held for sale (Note 18)
Impairment Of Asset Held For Sale Expense
Impairment Of Asset Held For Sale Expense
Amendment flag
Amendment Flag
Bad debt provision recognized to credit- impaired financial assets
Bad Debt Provision Recognized To Credit Impaired Financial Assets [Member]
Bad Debt Provision Recognized to Credit Impaired Financial Assets [Member]
Components of equity [domain]
Components of equity [domain]
Total
Expense of restructuring activities
Expense of restructuring activities
Dividends
Dividends recognised as distributions to owners
Post-employment Benefit
Description of accounting policy for employee benefits [text block]
Proceeds from sales and redemption of investments
Proceeds From Sale Of Investments
Proceeds From Sale Of Investments
Impairment losses
Right-Of-Use Assets, Impairment Losses
Right-Of-Use Assets, Impairment Losses
New, amended and terminated leases
Increase through new leases, liabilities arising from financing activities
Temporary difference, unused tax losses and unused tax credits [axis]
Temporary difference, unused tax losses and unused tax credits [axis]
Decreases (utilized)
Provision used, other provisions
Other liabilities
Disposal Group, Including Discontinued Operation, Other Liabilities1
Disposal Group, Including Discontinued Operation, Other Liabilities1
AbbVie break fee case with IRA
Litigation Settlements, AbbVie Break Fee Case With IRA [Member]
Litigation Settlements, AbbVie Break Fee Case With IRA
Range [domain]
Range [domain]
AMITIZA Antitrust Litigation, Third‑Party Payors
AMITIZA Antitrust Litigation, Third‑Party Payors [Member]
AMITIZA Antitrust Litigation, Third‑Party Payors
Total interest income
Interest income
ADVATE
Advate [Member]
Advate [Member]
Decrease in trade and other payables
Adjustments for increase (decrease) in trade and other payables
Marketed products
Marketed Products, Intangible Assets Other Than Goodwill [Member]
Marketed Products, Intangible Assets Other Than Goodwill [Member]
Customer risk concentration, net sales
Concentration Of Risk, Net Sales [Member]
Concentration Of Risk, Net Sales [Member]
Takeda Ireland Limited
Takeda Ireland Limited [Member]
Takeda Ireland Limited [Member]
Equity [Line Items]
Equity [Line Items]
[Line Items] for Equity [Table]
Repayments of long-term loans
Repayment Of Long-Term Borrowings
Repayment Of Long-Term Borrowings
Scenario [Domain]
Scenario [Domain]
Shire
Shire [Member]
Shire [Member]
Revenue that was included in contract liability balance at beginning of period
Revenue that was included in contract liability balance at beginning of period
Cencora Group
Cencora Group [Member]
Cencora Group, Previously Called AmerisourceBergen Corporation
Weighted average loss rate (%)
Expected credit loss rate
Transfers to investments accounted for using the equity method
Other Increase (Decrease), Fair Value Measurement, Transfer To Equity Method Investment
Other Increase (Decrease), Fair Value Measurement, Transfer To Equity Method Investment
Share-based compensation cost (reversal of cost)
Expense from share-based payment transactions
HEMOFIL/IMMUNATE/IMMUNINE
Hemofil/Immunate/Immunine [Member]
Hemofil/Immunate/Immunine
Disclosure of products and services [table]
Disclosure of products and services [table]
Hedging costs
Hedge Cost [Member]
Hedge Cost [Member]
Takeda Vaccines, Inc.
Takeda Vaccines, Inc. [Member]
Takeda Vaccines, Inc. [Member]
Cash:
Cash [abstract]
Remeasurement of defined benefit pension plans
Changes in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income [abstract]
Address type [Domain]
Address Type [Domain]
Principal amount in contractual currency (millions)
Notional
Contract amount
Notional amount
Schedule of Cash and Cash Equivalents
Schedule Of Cash And Cash Equivalents1 [Table Text Block]
Schedule Of Cash And Cash Equivalents [Table Text Block]
Cash flow hedges
Reserve of cash flow hedges [member]
Concentrations of risk [axis]
Concentrations of risk [axis]
Exchange differences on translation of foreign operations:
Exchange differences on translation [abstract]
Currency [Axis]
Currency [Axis]
Change in fair value of financial assets and liabilities associated with contingent consideration arrangements, net
Increase (decrease) in contingent consideration asset (liability)
Diluted earnings (loss) per share (in JPY per share)
Diluted earnings per share (in JPY per share)
Diluted earnings (loss) per share
Duration of the remaining performance obligations
Maturity [domain]
Ordinary Shares
Description of accounting policy for issued capital [text block]
Total PDT
PDT [Member]
PDT Immunology [Member]
Summary of Consolidated Subsidiaries
Disclosure of interests in subsidiaries [text block]
Ascentage Pharma
Ascentage Pharma [Member]
Ascentage Pharma
Takeda Nederland B.V.
Takeda Nederland B.V. [Member]
Takeda Nederland B.V.
Categories of financial liabilities [axis]
Categories of financial liabilities [axis]
Disclosure of terms and conditions of share-based payment arrangement [table]
Disclosure of terms and conditions of share-based payment arrangement [table]
ELAPRASE
Elaprase [Member]
Elaprase [Member]
Schedule of Reconciliation from Income Tax Expense (Benefit)
Disclosure Of Reconciliation Of Accounting Profit Multiplied By Applicable Tax Rates [Table Text Block]
Disclosure Of Reconciliation Of Accounting Profit Multiplied By Applicable Tax Rates And Average Effective Tax Rate [Table Text Block]
Disclosure of reconciliation of liabilities arising from financing activities [table]
Disclosure of reconciliation of liabilities arising from financing activities [table]
Fair value
At fair value [member]
Trade and other payables
Trade And Other Payables [Member]
Trade And Other Payables [Member]
Schedule of Basis for Calculating Basic and Diluted Earnings per Share
Earnings per share [text block]
Remeasurements of defined benefit pension plans
Reserve of remeasurements of defined benefit plans [member]
Intangible assets other than goodwill [abstract]
Counterparty Name [Axis]
Counterparty Name [Axis]
Protagonist, Contractual Commitments
Protagonist, Contractual Commitments [Member]
Protagonist, Contractual Commitments
Acquisition of option to license
Purchase Of Option To License
Purchase Of Option To License
Disclosure of detailed information about property, plant and equipment [table]
Disclosure of detailed information about property, plant and equipment [table]
Net defined benefit liabilities
Net defined benefit liability
Acquisition of intangible assets
Purchase of intangible assets, classified as investing activities
Entity incorporation, state or country code
Entity Incorporation, State or Country Code
Plan name [Domain]
Plan Name1 [Domain]
[Domain] for Plan Name [Axis]
Reclassification adjustments to profit or (loss)
Reclassification adjustments on cash flow hedges, before tax